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SUMMARY 
 
Synthetic biology can broadly be defined as a construction of new biological systems and 
modification of the existing ones. In recent years, synthetic biology has presented itself 
as a potential solution to many global challenges - e.g., climate change and scarcity of 
natural resources. The progress of synthetic biology is, however, largely reliant on the 
availability of a large repertoire of functional genetic parts.  As a result, there exists an 
urgent need for enhancing and expediting the process of tapping into genetic diversity - 
both natural and laboratory-induced.  
Analysing the current landscape of synthetic biology and various approaches of accessing 
biological diversity, two high-impact areas, namely the basic molecular cloning and 
identification of genes encoding for complex microbial phenotypes, have been identified 
as particularly lacking and, as such, constitute the focal point of my PhD project. The 
culmination of the work presented in this dissertation are two molecular methods, 
QuickStep-Cloning and Multi-Genius, that aim to accelerate the development of 
synthetic biology. 
QuickStep-Cloning is a new molecular cloning technique that builds upon recent 
advances in megaprimer-based cloning to allow for seamless integration of a DNA 
fragment of interest into a plasmid in less than 6 hours – the result that could not be 
reproduced using state-of-the-art methods. The new improved version of the method, 
QuickStepS-Cloning, utilises phosphorothioate oligonucleotides to not only simplify the 
overall procedure but also significantly increase its cloning efficiency. It also shown that 
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incorporating random mutagenesis into the method allows for streamlining directed 
evolution experiments.   
Whereas the potential applications of QuickStep-Cloning revolve around artificially-
induced diversity, Multi-Genius builds upon the concept of genomic libraries to tap into 
naturally-existing diversity and expedite identification of genes encoding for useful 
phenotypes. The usefulness of the method has been proven by isolating thermotolerant 
variants of Escherichia coli DH5α and indentifying the gene responsible for the observed 
phenotype.  
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General introduction 
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1.1 Brief introduction to synthetic biology 
Synthetic biology is an emerging area of research that encompasses many traditional 
branches of molecular biology and biotechnology, and strives to develop novel biological 
systems and devices. There exist several working definitions of synthetic biology. 
According to the Royal Society, synthetic biology can be described as the design and 
construction of novel artificial biological pathways, organisms or devices, or the redesign of 
existing natural biological systems (The Royal Society, 2007). At its inception, the 
emphasis of synthetic biology centred around the concepts of de novo design and 
construction of biological systems from standardised biological components, analogous 
to how computers and other sophisticated electronic systems are built from transistors 
and other basic electronic components. In order to achieve this aim, synthetic biologists 
try to apply engineering principles – e.g., abstraction and standardisation - to biological 
systems.  
A primary example of the underlined approach is Registry of Standard Biological Parts, a 
large repository of a wide range of biological components, such as promoters, ribosome 
binding sites and reporter proteins. The available genetic parts conform to BioBrick 
assembly standard (Knight, 2003), allowing to combine them in a relatively simple and 
time-efficient manner. Furthermore, the functionality of many genetic parts is well 
characterised to make sure that selected components are fit for purpose - e.g., selected 
promoter allows for a desired expression level. As such, the Registry of Standard 
Biological Parts constitutes one of the first attempts of applying the concepts of 
modularity and standardisation, fundamental engineering principles, to biological 
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systems. It is worth noting that the repository is used every year by undergraduate 
students from around the world to design and build functional biological devices, as part 
of the International Genetically Engineered Machine competition, iGEM.  
As synthetic biology is still in a phase of rapid development, many of the reported 
breakthroughs revolve around proof-of-concept research or development of much-
needed enabling tools. Well-known examples of this approach include genetic circuits 
(Nandagopal and Elowitz, 2011; Siuti et al., 2013) and Synthia (Gibson et al., 2010), 
the first living organism based on purely synthetic chromosomal DNA, developed by 
researchers at the J. Craig Venter Institute. 
At the same time, an increasing number of synthetic biologists demonstrate the 
usefulness of the available molecular tools by attempting to tackle various global 
challenges.  One of such issues has been the production of artemisinin, a common 
antimalarial drug - recommended for the treatment of malaria caused by a protozoan 
parasite, Plasmodium falciparum. Artemisinin originates from the plant Artemisia annua 
(known also as sweet wormwood) and its discovery was a focal point of Nobel Prize in 
Physiology or Medicine in 2015 won by Tu Youyou (Guo, 2016). As artemisinin needs 
to be isolated from A. annua, its availability and cost is heavily dependent on the erratic 
supply of the plant (Van Noorden, 2010). To address this problem, Jay Keasling and his 
team from the University of California, Berkley, utilised a synthetic biology approach to 
incorporate the metabolic pathway responsible for synthesis of an artemisinin precursor 
into yeast (Ro et al., 2006), providing an alternative way of acquiring the drug. The 
method has been commercialised and used for industrial production of semi-synthetic 
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artemisinin by the French pharmaceutical company Sanofi (Paddon and Keasling, 
2014). Despite the fact that, due to complex socio-economic factors, artemisinin 
remains to be produced primarily from the plant-based material (Peplow, 2016), this 
story clearly demonstrates the immense potential of synthetic biology in tackling global 
challenges.  
If achieved, the ability to freely design and engineer new, functional biological systems 
and devices would, undoubtedly, bring countless benefits. Production of 
pharmaceuticals is only one of the many examples of potential applications of synthetic 
biology, such as biosensor-based devices, productions of biofuels and removal of toxic 
contaminants from the environment (Choffnes et al., 2011; Konig et al., 2013).  Many 
of the most pressing global challenges – e.g., scarcity of natural resources, environmental 
degradation, climate change and infectious diseases – could potentially be solved by 
judicious application of such technology. Unfortunately, experience shows that there 
exist detrimental differences between living organisms and electronic systems that make 
the concept of de novo design difficult to achieve in practice. Intrinsic biological 
complexity, a sheer number of functional components, complex, nonlinear interactions, 
constant evolution of biological organisms and spontaneous variations in the behaviour 
of biological systems – these are only some of the challenges that synthetic biologists 
have to cope with, in order to construct fit-for-purpose biological devices from 
standardised biological components. These challenges have been  succinctly described in 
2010 article written by Roberta Kwok titled ‘Five hard truths for synthetic biology’ 
(Kwok, 2010). The titular ‘hard truths’ are the main challenges that, according to the 
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author, constitute the biggest hindrance to the development of synthetic biology – 
poorly defined biological parts, the unpredictability of biological circuitry, the intrinsic 
complexity, incompatibility of biological components and ubiquitous variability of 
biological systems. As such, the progress of synthetic biology is largely reliant on the 
constant supply of well-defined biological parts that can be combined together, in a 
predictable fashion, to create functional devices. It is also important to note that the 
main factor behind the discussed problem of biological complexity is the need of 
constructing and testing a large amount of biological circuits in order to find one that 
fulfils all the necessary design criteria.  As such, any technique that expedite such process 
could be of great benefit to the field of synthetic biology.                                                                                                                               
The distinctive nature of biological systems, while being a major hindrance to applying 
engineering strategies to biology, provides unique opportunities if properly utilised. 
Natural biological diversity constitutes a nearly unlimited source of biological 
components. Methods such as metagenomics attempt to tap into this largely 
unexploited potential. Whereas constant evolution of biological systems interferes with 
the construction of well-defined biological devices, strategies such as directed evolution 
make use of evolution to improve, or even develop, useful properties of proteins by 
further expanding the existing biological diversity. In the same way, adaptive evolution 
is routinely used to improve, for instance, industrially-relevant bacterial strains. 
By tapping into biodiversity - both natural and laboratory-induced, those methods 
perfectly complement the traditional synthetic biology approach, by not only providing 
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an alternative way of engineering biological systems but also they constitute an 
invaluable source of new genetic parts. 
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1.2 Natural biodiversity 
This section reviews different approaches to accessing natural biological diversity and provides 
a comprehensive overview of metagenomics in the context of novel biomolecule discovery. It 
has been adapted from: 
Jajesniak P, Wong TS. (2015) Tapping into biodiversity: From metagenomics to industrial 
enzymes. In: Biodiversity and Conservation (Vol. 2). USA: Studium Press LLC. 
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1.3 Directed evolution 
This section introduces the concept of protein engineering as a powerful tool for expanding 
genetic diversity, beyond its natural pool, and demonstrates that it perfectly complements 
metagenomics. The section also emphasises the importance of molecular cloning in the context 
of directed evolution experiments. It has been adapted from: 
Jajesniak P, Wong TS. (2015) Tapping into biodiversity: From metagenomics to industrial 
enzymes. In: Biodiversity and Conservation (Vol. 2). USA: Studium Press LLC. 
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1.4 Diversity of non-coding DNA sequences 
This section expands the discussion of genetic diversity beyond genes and proteins - to other 
non-coding DNA sequences. Section 1.4 focuses specifically on bacterial promoters as arguably 
one of the most crucial types of non-coding DNA sequences and demonstrates their 
importance in the context of synthetic biology. In addition, the information presented in here 
facilitated the judicious choice of a suitable promoter for Multi-Genius method, as described 
in Chapter 4. Finally, this literature review provides a necessary context for the subsequent 
discussion of new methods of engineering prokaryotic organisms, via simultaneous alteration 
of multiple genes, presented in Section 1.5. It has been adapted from: 
Jajesniak P, Wong TS. (2015) From genetic circuits to industrial-scale biomanufacturing: 
bacterial promoters as a cornerstone of biotechnology. AIMS Bioengineering, 2(3), 277-296. 
1.4.1 Introduction 
Bacteria are widely known as one of the most abundant and ubiquitous groups of living 
organisms known to man, and their importance to life sciences research over the past 
decades cannot be overstated. The prevalence of bacteria can be attributed not only to 
their high diversity, exceptional evolvability and short generation time but also to their 
robust mechanism of gene regulation. Individual bacterial cell can quickly and efficiently 
adapt to new environment by redirecting its metabolic flux and adjusting its protein 
content in response to external stimuli (e.g.¸ production of β-galactosidase, lactose 
permease, and galactoside O-acetyltransferase by Escherichia coli in response to the 
presence of lactose in glucose-deficient medium) (Gorke and Stulke, 2008; Jacob and 
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Monod, 1961). Such a tight control of catabolic, biosynthetic and stress-response 
pathways (to name but a few) within a cell allows for a highly efficient utilization of 
naturally scarce resources.  
Recent advances in our understanding of bacterial systems have provided the scientific 
community with an expanding molecular toolbox for altering and manipulating the 
genetic makeup of various bacterial species. Our ability to engineer biological organisms 
for useful purposes has sparked the development of synthetic biology and metabolic 
engineering. Despite the growing number of enabling technologies, transcriptional 
regulation still takes the centre stage in engineering prokaryotic organisms. Careful 
selection of promoter plays a critical role in maximizing bioproduct yield and, as a 
result, is key to biomanufacturing industry (Terpe, 2006; Weickert et al., 1996). While 
bioprocess specialists are, more often than not, interested in strong, inducible promoters 
with low or nonexistent basal expression profiles, metabolic engineers and synthetic 
biologists utilize various types of promoters for their work, which includes, but is not 
limited to, the design of genetic circuits and construction of heterologous biosynthetic 
pathways (Blazeck and Alper, 2013). Consequently, the demand for reliable and well-
characterized promoters of different types is steadily increasing in various areas of 
biological research. As basic techniques of promoter engineering and characterization are 
becoming more and more accessible, there has been a large number of exciting 
developments in the field of transcriptional regulation in recent years. 
In this section, I aim to provide a comprehensive overview of bacterial promoters 
research and engineering, with an emphasis on their application in recombinant protein 
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production, synthetic biology and metabolic engineering. First, I give a brief outline of 
prokaryotic gene regulation from a theoretical standpoint, highlighting the ramifications 
of biological complexity and ubiquity of nonlinear biomolecular interactions in the 
context of promoter engineering and design. Subsequently, I explore the role of 
promoters in large-scale protein production, discussing promoter selection criteria and 
recent advances in this area. This is followed by a summary of scientific endeavours in 
the field of synthetic biology and metabolic engineering that are centred around 
transcriptional regulation. I delve into the subject of promoter databases and associated 
bioinformatics tools, and the idea of describing promoters as standardized biological 
parts is carefully scrutinized. The review concludes by highlighting emerging 
technologies that complement transcriptional regulation and exploring future prospects 
of this research area.   
1.4.2 Theoretical background 
Over the past half a century, gene regulation in bacteria has been extensively studied. 
Although many details concerning their complex regulatory mechanisms are still 
unknown, major progress has been made in our understanding of their cellular 
machineries. Detailed mechanism of DNA transcription, promoter architecture and 
three-dimensional structures of transcription factors are only a few examples of what the 
scientific community has gathered, over this short time period, through combination of 
ingenious experimentation and rigorous data analyses. This information has enabled not 
only the development of more advanced molecular tools for engineering prokaryotic 
  
 
| 62 | 
organisms but also shed light on the far more complex mechanisms of eukaryotic gene 
regulation. 
 
Figure 1.6  Outline of prokaryotic promoter structure - simplified structure and 
consensus sequence of E. coli σ70 promoter. During promoter 
recognition, σ4 and σ2 domains of σ70 factor (subunit of RNA 
polymerase holoenzyme) bind to -35 and -10 motifs, respectively, 
allowing for transcription initiation (Busby and Ebright, 1994). After the 
two DNA strands are separated by RNA polymerase, a single nucleoside 
triphosphate pairs itself with a nucleotide constituting transcriptional 
start site (+1 position) and becomes 5’ end of growing RNA transcript, 
created during the elongation process. 
Escherichia coli, the workhorse in laboratory, has been extensively studied as a model 
system of bacterial gene regulation. Since the inception of gene transcription studies, 
promoter has been described as one of the most fundamental regulatory elements 
present in bacterial operons. Based on numerous sequencing experiments, their relatively 
simple structure has been determined and is widely available (Figure 6) (Harley and 
Reynolds, 1987; Hawley and McClure, 1983; Oliphant and Struhl, 1988). Promoters, 
however, should rarely be analysed in isolation - it is the complex interplay between a 
promoter (including its operators), RNA polymerase holoenzyme, transcription factors 
and effector molecules that gives rise to different rates of transcription initiation (Busby 
-35 motif -10 motif Start site
Spacer Spacer
TTGACA (N 17) TATAAT (N 5-9) A/G
Consensus 
sequence
Promoter
structure
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and Ebright, 1994; Ishihama, 1993), which, more often than not, significantly influence 
the final expression levels of regulated proteins. Even a single-base substitution or 
deletion can have a detrimental effect on binding energies of DNA-protein and protein-
protein complexes (Ebright et al., 1984; Lewis et al., 1996) and, consequently, alter the 
properties of the whole system. Moreover, interactions between individual elements of 
the regulatory system are not always linear. For example, stronger binding between RNA 
polymerase holoenzyme and the promoter sequence is frequently associated with a 
higher rate of transcription initiation, however, increased stabilization of RNA 
polymerase complex sometimes has the opposite effect – transcription inhibition can be 
achieved by preventing RNA polymerase from leaving a promoter (e.g., phage φ29 
regulatory protein p4 that binds to A2c promoter acts as a transcription repressor via 
this mechanism) (Monsalve et al., 1998). The outlined biological complexity makes 
engineering of promoters a very challenging task and favours the use of random and 
semi-rational strategies such as directed evolution for this purpose. 
The subject of transcriptional gene regulation in bacteria has been covered from a 
theoretical standpoint in many excellent reviews (Balleza et al., 2009; Browning and 
Busby, 2004) and textbooks devoted to general biochemistry and molecular biology. As 
such, I  kindly invite any readers interested in exploring, in more details, theoretical 
basis of the outlined mechanisms to consult the relevant resources.  
1.4.3 Promoter engineering 
In light of biological complexity, outlined in the previous section, de novo design is still a 
largely unfeasible method of acquiring novel prokaryotic promoters. Most of the new 
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bacterial promoters of biotechnological significance are a result of promoter engineering 
or, more specifically, the three main strategies of prokaryotic promoter engineering – 
saturation mutagenesis of spacer regions (Figure 6), error-prone PCR and hybrid 
promoter engineering (Blazeck and Alper, 2013).  
During saturation mutagenesis of spacer regions, mutagenic oligonucleotides are 
designed to vary the nucleotide sequence surrounding -35 and -10 motifs (Figure 6). 
This semi-rational strategy relies on the fact that extensive changes to promoter 
consensus regions, in most cases, significantly decrease binding of RNA polymerase 
molecule and, consequently, leaving them unchanged allows for a dramatic decrease in 
the number of non-functional promoter variants. Moreover, varying the spacer length is 
often unnecessary as the variable region between the two motifs has a constant optimal 
length (17 base pairs in the case of many E. coli promoters) (Aoyama et al., 1983; 
Mulligan et al., 1985). The discussed method has been used, for example, to create a 
library of synthetic promoters of varying strength for bacteria Lactococcus lactis (Jensen 
and Hammer, 1998) and Lactobacillus plantarum (Rud et al., 2006).  
A complementary strategy to saturation mutagenesis of spacer regions is error-prone 
PCR, which was used, in combination with green fluorescent protein (GFP) expression 
and flow cytometry, to modify constitutive bacteriophage PL promoter and create a 
library of 22 synthetic promoters of varying strength (Alper et al., 2005). Both methods, 
saturation mutagenesis of spacer regions and error-prone PCR, are claimed to be fairly 
equal in terms of the number of advantages and disadvantages, with a major difference 
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being that error-prone PCR involves screening libraries with a lower fraction of 
functional promoters (Table 1.3).  
Table 1.3 Comparison between two main strategies of promoter engineering - 
saturation mutagenesis of spacer regions and error-prone PCR (based on 
the information provided in (Alper et al., 2005; Hammer et al., 2006; 
Jensen and Hammer, 1998)). 
 
Saturation mutagenesis of 
spacer regions Error-prone PCR 
Target Spacer regions Whole promoter 
Theoretical library size >417 >435 
Fraction of functional library 
members 
>50% <1% 
Reported screening technologies Colorimetric assays 
Colorimetric assays 
Flow-cytometry 
Reported variation in promoter 
strength 
400-fold 196-fold 
 
The third strategy of obtaining new synthetic promoters is hybrid promoter engineering, 
which involves merging promoter parts from different sources. For example, the widely-
used tac promoter is a hybrid of trp and lac promoters (de Boer et al., 1983). The region 
upstream of -20 position, with respect to transcriptional start site, derives from trp 
promoter whereas the rest originates from lacUV5 promoter (mutant of lac promoter 
that is no longer sensitive to catabolite repression). The resultant promoter is 3 and 11 
times more efficient than trp and lac promoter, respectively, and remains inducible by 
isopropyl β-D-1-thiogalactopyranoside (IPTG). Other examples of hybrid promoters 
include Bacillus subtilis PSPAC promoter (Yansura and Henner, 1984) and E. coli rhaPBAD 
expression system (Haldimann et al., 1998). 
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It is worth mentioning that advances in the field of promoter engineering come not only 
from new methods of creating combinatorial libraries but also from developments in 
screening technologies. As mentioned, use of GFP expression along with flow cytometry 
allowed for high-throughput screening of promoter library and identifying promoter 
variants of different strengths (Alper et al., 2005). This approach facilitates screening of 
large combinatorial libraries, the size of which, however, is limited by efficiency of 
bacterial transformation. In vitro compartmentalization, a method of utilizing a water-
in-oil emulsion and in vitro transcription/translation to create vast combinatorial 
libraries (Tawfik and Griffiths, 1998), was successfully used for directed evolution of 
peptides (Yonezawa et al., 2003), ribozymes (Levy et al., 2005) and proteins (Ghadessy 
et al., 2001; Griffiths and Tawfik, 2003, 2006; Sepp and Choo, 2005). Recently, this 
technique was demonstrated to be applicable to promoter engineering – use of in vitro 
compartmentalization led to identification of T7 promoter variant with a 10 times 
higher in vitro transcriptional activity (Paul et al., 2013). 
1.4.4 Protein expression and promoter selection 
Production of proteins, especially industrial enzymes, monoclonal antibodies and other 
biopharmaceuticals, remains a core activity of current biotechnological industry. Owing 
to their short generation times and relative ease of genetic manipulations, bacteria are 
widely utilized as protein expression platforms, despite their inability to perform post-
translational modifications (Porro et al., 2011). E. coli is, without a doubt, a workhorse 
of bacterial protein manufacturing, accounting for production of nearly a third of 211 
biopharmaceuticals approved by the end of year 2011 (Berlec and Strukelj, 2013; 
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Walsh, 2014). Several Bacillus species (i.e., Bacillus brevis, Bacillus megaterium and 
Bacillus subtilis) are also used as common biomanufacturing platforms, however, their 
utilization is mainly limited to production of homologous enzymes (e.g., proteases and 
amylases) (Liu et al., 2013; Westers et al., 2004). Rapid advances in genetic engineering 
and constant development of new molecular tools have contributed to identification of 
new platforms for recombinant protein production – for examples, several bacterial 
species belonging to Pseudomonas genus (e.g.¸ Pseudomonas fluorescens) have been 
reported to provide protein yield comparable or higher than E. coli and were utilised for 
biopharmaceutical production (Chen, 2012; Retallack et al., 2012). Various other 
bacterial species, distinct form E. coli, are sometimes used for industrial-scale protein 
production, however, the prevalence of such cases still remains quite low (Chen, 2012; 
Terpe, 2006).  
 
Figure 1.7  Main factors affecting protein expression levels during heterologous protein 
production.  
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Selecting the right host organism is only one example among a myriad of different 
variables (Figure 7) that one has to consider to maximize the production yield of 
functional protein (Gopal and Kumar, 2013; Liu et al., 2013; Rosano and Ceccarelli, 
2014; Sorensen and Mortensen, 2005; Weickert et al., 1996). Among these decisions, 
an appropriate promoter is, arguably, one of the most crucial and impactful factors. In 
many cases, when protein production is concerned, the desired specifications of a 
promoter are well-defined – it should allow for robust, responsive and low-cost 
induction, be characterised by relatively low basal expression level, and maximize the 
final yield of functional protein. Unfortunately, looking at the list of most common E. 
coli expression systems and their properties (Table 1.4), it becomes immediately 
apparent that these criteria are often at odds with one another. For example, T7 
expression system, characterised by the highest expression level, is associated with one of 
the most expensive inducers (i.e., IPTG) and a considerable basal expression level (Pan 
and Malcolm, 2000). To be fully functional, T7 promoter also requires the presence of 
T7 RNA polymerase, which has to be encoded on an additional plasmid or, more 
commonly, within the bacterial chromosome - e.g., E. coli BL21 (DE3), C41 (DE3) and 
C43 (DE3). Further, it is vital to note that the strength of a promoter does not always 
correlate with the final yield of functional protein. T7 promoter is notorious for 
producing a high fraction of insoluble protein, which frequently aggregates into 
intracellular inclusion bodies (Balzer et al., 2013; Tegel et al., 2011). Finally, a low 
expression level or low promoter leakiness is sometimes advantageous when expressing 
membrane proteins or other toxic biomolecules (Rosano and Ceccarelli, 2014; Terpe, 
2006). 
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Table 1.4 Most commonly-used inducible E. coli expression systems and their important properties (adapted from (Terpe, 2006) and (Weickert 
et al., 1996)); inducer prices are based on the information provided by Sigma-Aldrich Corporation, http://sigmaaldrich.com). 
Name Expression level Basal expression Catabolite repression Inducer Inducer cost References 
lac Low-medium High Yes IPTG High (63.90 $/g) (Gronenborn, 1976) 
lacUV5 Low-medium High Reduced (1) IPTG High 
(63.90 $/g) 
(Silverstone et al., 1970; Wanner 
et al., 1977) 
trp High High No IAA (2) High (61.20 $/g) 
(Bass and Yansura, 2000; 
Somerville, 1988) 
tac High High Reduced (1) IPTG High (63.90 $/g) (de Boer et al., 1983) 
trc High High Reduced (1) IPTG High 
(63.90 $/g) 
(Brosius et al., 1985) 
phoA High Low No Phosphate starvation - (Craig et al., 1991; Neubauer and Winter, 2001 ) 
PL High Low (3) No Temperature shift - 
(Elvin et al., 1990; Valdez-Cruz 
et al., 2010) 
tetA Medium-high (4) Low No Anhydrotetracycline Low 
(1.67 $/mg) (5) 
(Skerra, 1994) 
araBAD 
(PBAD) 
Low-high (4) Low Yes L-arabinose 
Low 
(2.30 $/g) 
(Guzman et al., 1995; Siegele and 
Hu, 1997) 
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rhaPBAD Low-high (4) Low Yes L-rhamnose 
High 
(61.30 $/g) 
(Haldimann et al., 1998) 
T5/lac Very high High No IPTG High 
(63.90 $/g) 
(Deuschle et al., 1986; Gentz and 
Bujard, 1985; Samuelson, 2011) 
T7 (6) Very high High (7) Reduced (1) IPTG 
High 
(63.90 $/g) 
(Studier and Moffatt, 1986) 
T7/proU Very high Low No NaCl Very low 
(40 $/kg) 
(Donahue Jr and Bebee, 1999) 
(1) The mutation of lac promoter reduces its sensitivity to catabolite repression, however, it does not fully eliminate it (Rosano and Ceccarelli, 2014). 
(2) IAA denotes 3-β-indoleacrylic acid. The promoter can also be induced by low intracellular level of L-tryptophan (nutrient starvation) (Somerville, 1988; Weickert et al., 1996).  
(3) At 29-30˚C - the temperature at which repressor cI857 is fully functional (Lowman and Bina, 1990). 
(4) Titratable. 
(5) The amount of anhydrotetracycline commonly used for full induction of tetA promoter (200 µg/l) is, on average, 100-1000 lower than the amount of chemical inducer required 
for induction of the remaining promoters (Bass and Yansura, 2000; Terpe, 2006). 
(6) Includes both lac- and lacUV5-based expression systems. 
(7) New strategies, which aim to provide lower basal expression levels of T7 expression system, have been developed (Pan and Malcolm, 2000; Studier, 1991). 
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As a result, the choice of an appropriate expression system is often dependent on the 
target protein and, consequently, promoter selection remains a challenging, yet crucial 
task. To enable easier navigation among the various selection criteria and facilitate the 
process of promoter selection, decision diagram presented in Figure 8 provides an easy 
way of determining which of the commonly used inducible expression systems is the 
most adequate for a given application. 
 
Figure 1.8  Proposed flowchart for a quick selection of an appropriate inducible 
promoter (based on the list of 13 most common inducible E. coli 
expression systems listed in Table 1.2). (1) At the start of the selection 
process, desired expression level should be chosen, taking into account 
protein solubility and toxicity – in the case of poorly soluble or toxic 
proteins, final product yield is often maximized by choosing a promoter 
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capable of low expression. (2) When glucose-based medium is to be used 
for cell culture, expression systems with a high dependency on catabolite 
repression system should be avoided. (3) Selecting promoter with  a low 
basal expression is vital for expression of membrane proteins or other 
toxic biomolecules. (4) The cost of chemical inducer is a vital factor for 
large-scale protein production. (5) Choice between IPTG- and IAA-
dependent promoters is likely to be based on the availability of the 
particular chemical inducer. (6) When addition of chemical inducer 
during cell culture is deemed to be infeasible, other induction strategies 
should be considered. (7) In the situation where temperature change of 
bacterial culture can be easily achieved, use of PL expression system is 
recommended as it does not impose any limitations on media 
composition. Otherwise,  phoA expression system should be used. 
As many promoters exhibit, at least some, undesirable properties, it is not surprising that 
different strategies, including promoter engineering, have been utilized to enhance their 
characteristics or even develop novel expression systems (e.g. propionate-inducible (Lee 
and Keasling, 2005) and cumate-inducible (Choi et al., 2010) expression systems). 
Among different targets of these endeavours, efficient production of toxic proteins is 
prioritized (Saida et al., 2006). Development of E. coli expression system dependent on 
ferric uptake regulator (Fur), which exhibits relatively high expression and tight 
regulation, illustrates the rapid progress in this area (Guan et al., 2013). Table 1.5 
provides a comprehensive overview of some recently-reported expression systems 
developed for three prokaryotic groups of major bioprocessing importance - E. coli, 
Bacillus spp. and Pseudomonas spp. 
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Table 1.5 Novel expression systems developed for Escherichia coli, Bacillus spp. and Pseudomonas spp. over the last decade. 
Organism Name Important characteristics Reference 
E. coli 
Propionate-inducible expression system (PprpB) 
• Homogenous expression 
• Wide range of inducer-dependent 
expression level 
(Lee and Keasling, 
2005) 
Cumate-inducible expression system 
• Tight regulation 
• High-level and homogenous expression 
• Wide range of inducer-dependent 
expression level 
(Choi et al., 2010) 
Gene expression system Hsh 
• Heat-shock inducible expression 
• Very high expression level 
(Wu et al., 2010) 
pLAI expression system 
• Expression triggered by high-cell density 
• Tight regulation 
• Low-level basal expression 
(Nocadello and 
Swennen, 2012) 
Fur-dependent expression system (PfhuA) 
• Tight regulation 
• Suitable for toxic protein synthesis 
(Guan et al., 2013) 
B. subtilis 
Subtilin-regulated gene expression (SURE) 
• Very high expression level 
• Low-level basal expression 
(Bongers et al., 2005) 
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• Not subjected to catabolite control 
Maltose-inducible expression system • High-level expression 
(Ming-Ming et al., 
2006; Ming et al., 
2010) 
Cold-inducible expression system • Temperature-inducible expression 
(Thuy Le and 
Schumann, 2007) 
B. megaterium 
Sucrose-inducible promoter system (PsacB) 
• Alternative to a well-established xylose-
inducible promoter system (comparable 
expression levels) 
(Biedendieck et al., 
2007) 
T7 RNA polymerase-dependent expression system 
• High-level expression 
• Reported difficulties with extracellular 
protein expression 
(Gamer et al., 2009) 
Pseudomonas spp. PBAD-based shuttle vectors  • Highly-regulated expression (Qiu et al., 2008) 
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As addition of chemical inducer to bacterial culture is often problematic (e.g., potential 
of contamination) and expensive in large-scale protein production, much effort in 
enhancing current expression systems is concentrated around alleviating this problem. 
Use of temperature-inducible promoters, such as bacteriophage PL promoter under the 
control of temperature-sensitive repressor cI857, constitutes a solution to this problem 
(Elvin et al., 1990; Valdez-Cruz et al., 2010), however, this strategy is not free from its 
inherent drawbacks. Heating large volumes of fermentation broth is not only 
challenging from an engineering and economic standpoint but can also have serious 
ramifications for the stability of temperature-sensitive proteins. As a result, the 
introduction of auto-induction media for T7 expression system has been a major 
breakthrough in protein expression (Studier, 2005). Auto-induction medium contains a 
substantial amount of glucose, which in combination with other specified culture 
conditions inhibits protein production at the early stage of cell growth; only after 
glucose is depleted, protein expression takes place (Studier, 2005, 2014). The 
widespread adoption of this method has motivated other researches to develop new 
strategies of auto-induction. For instance, utilization of a quorum sensing system from 
Vibrio fischeri allowed for creating E. coli expression system that couples protein 
production with cell density (Nocadello and Swennen, 2012).  
Recent emergence of robust cell-free expression systems (Carlson et al., 2012; Katzen et 
al., 2005; Schwarz et al., 2008) necessitates development of promoters that are fully 
compatible with in vitro transcription/translation mixtures. As discussed above, the use 
of in vitro compartmentalization allowed for identification of T7 promoter mutant with 
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a 10 times higher in vitro transcriptional activity (Paul et al., 2013). Moreover, studies 
on transcription factors and RNA polymerase bring a wealth of information that could 
prove invaluable for promoter engineering. For example, T7 RNA polymerase mutation 
that decreases its propensity for abortive transcription and, consequently, increases its in 
vitro transcription efficiency, was reported (Guillerez et al., 2005). 
1.4.5 Synthetic biology and metabolic engineering 
The two emerging areas of biological research, synthetic biology and metabolic 
engineering, have been, for quite some time, a rich source of invention and scientific 
progress. Regardless of some differences between the two disciplines – e.g., synthetic 
biology is in principle more concerned with de novo design, whereas the efforts of 
metabolic engineers are concentrated on modifying existing biological pathways (both 
endogenous and heterologous)  - they both share the common goal of devising useful 
biological systems. As a result, it is also not surprising that both disciplines are currently 
deeply intertwined (Yadav et al., 2012).  
In contrast to heterologous protein production, metabolic engineering is characterized 
by a frequent use of constitutive promoters (Mijakovic et al., 2005). Because 
construction of optimized metabolic pathways usually requires expression of individual 
genes to be at different, yet well-defined levels, there exists a high demand for libraries of 
synthetic constitutive promoters of different strength. As mentioned in the promoter 
engineering section, both saturation mutagenesis of spacer regions and error-prone PCR 
have been extensively used to create such libraries (Alper et al., 2005; Jensen and 
Hammer, 1998; Rud et al., 2006). 
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Altering promoter strength is one of the main methods of optimizing metabolic 
pathways. Due to this fact, various inducible promoters play an essential role in the 
development of metabolic engineering. Use of inducible araBAD expression system 
allowed for modulating individual gene expression levels  (by changing arabinose 
concentration) and, consequently, removing a bottleneck from E. coli mevalonate 
pathway (Pitera et al., 2007). By utilizing promoters of different strength (lac, lacUV5 
and trc), Anthony et al. alleviated two pathway bottlenecks and achieved a 5-fold 
increase in amorphadiene production, a precursor to anti-malarial compound (Anthony 
et al., 2009). Finally, T5, T7 and trc inducible promoters were used to carefully 
optimize two metabolic pathways in order to maximize the titers of taxadiene, a 
precursor to potent anticancer drug Taxol (Ajikumar et al., 2010). A 15000-fold 
increase in its production was reported. 
Inducible expression systems are also a central part of synthetic biology. Genetic circuits 
constitute a great example of how simple biological components, including promoters, 
can be assembled into fully functional biological systems with complex properties, which 
significantly differ from the properties of the individual components. For instance, 
combining three transcriptional repressor systems resulted in construction of synthetic 
oscillatory network, with typical period of hours (Elowitz and Leibler, 2000). On the 
other hand, use of two repressible promoters arranged in a mutually inhibitory network 
allowed for the development of a genetic toggle switch in E. coli (Gardner et al., 2000). 
Recently, design and construction of genetic circuits moved towards closer integration 
between synthetic and endogenous circuitry (Elowitz and Leibler, 2000) – e.g., B. subtilis 
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gene circuit responsible for inducing transient cell competency was analyzed in details 
and re-engineered to prevent the cells from exiting the competency state (Suel et al., 
2006).  
1.4.6 Databases and bioinformatics tools 
Advances in promoter engineering and steady growth in the number of available 
promoters have sparked the development of complementary databases and 
bioinformatics tools. Arguably, one of the most known database of biological parts is the 
iGEM registry (recognized also under the name of the Registry of Standard Biological 
Parts; http://parts.igem.org). The database includes hundreds of functional promoters 
and is used each year by students around the world to construct functional biological 
systems as part of the International Genetically Engineered Machine (iGEM) 
competition. The listed promoters conform to the BioBrick standard, allowing for their 
quick assembly together with other functional components provided by the repository 
(Shetty et al., 2008). The database consists of both inducible and constitutive 
promoters, including a set of 20 constitutive promoters of various strengths. The vast 
majority of promoters listed in the iGEM registry are designed with E. coli in mind, 
however, the number of functional components conforming to BioBrick standard 
created for use with other organisms, e.g., Bacillus subtilis, is slowly increasing (Radeck et 
al., 2013). It should be noted that all promoter entries present in the database provide 
information about their DNA sequence, allowing for their in-house or commercial 
syntheses thereby alleviating the need of requesting them from the registry. Promoter 
databases other than the iGEM registry have been created – for example, PromEC 
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database provide DNA sequences of all endogenous E. coli promoters (excluding their 
regulatory elements) (Hershberg et al., 2001) and DBTBS database lists upstream 
regulatory elements of B. subtilis (Ishii et al., 2001; Makita et al., 2004; Sierro et al., 
2008). Nevertheless, they often provide little to no information about properties of the 
listed promoters. 
Much effort in the area of bioinformatics concerned with prokaryotic microorganisms 
has been devoted to the development of reliable promoter prediction tools. Their 
usefulness is certainly not limited to facilitating the identification of novel regulatory 
elements - they constitute an essential part of genome analysis and annotation. As a 
result, advances in promoter recognition and developments in the field of operon 
prediction software are often closely intertwined. Finally, ability to reliably detect 
promoter sequences can help immensely in preventing introduction of unwanted 
transcription initiation sequences when creating biomolecular constructs (Yao et al., 
2013). A great example of program capable of predicting prokaryotic promoters and 
regulon is PePPER (de Jong et al., 2012). This web server allows for a quick 
identification of prokaryotic promoters based on the recognition of -35 and -10 
promoter DNA motifs. This prediction is not error-free and, consequently, the existence 
of both undetected sequences and false positives should be taken into account when 
analyzing results from this program.  
It is worth mentioning that the list of bioinformatics tools aiming to expedite the design 
of synthetic biological systems, from individual components, is steadily increasing and 
includes programs such as GenoCAD (Czar et al., 2009), TinkerCell (Chandran et al., 
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2009) and Synthetic Biology Software Suite (SynBioSS) (Hill et al., 2008; Kaznessis, 
2011). These programs aim to mimic computer-aided design (CAD), hugely popular 
among many engineering disciplines, and bridge the gap between the vast amount of 
biological data and computational modelling. In comparison to original engineering 
programs, however, these tools still lack certain functionalities. One of which is 
incorporating functional properties of individual biological part (e.g., promoter activity). 
1.4.7 Standardization and quantification of promoter strength 
Availability of standardized and well-defined biological components is one of the main 
premises of synthetic biology (Andrianantoandro et al., 2006; Endy, 2005) and one of 
the most promising methods of accelerating the development of biological research. The 
iGEM registry constitutes a first step towards standardization of biological components 
by providing a common method of assembling them into complex biomolecular 
constructs (all functional DNA sequences are flanked by well-defined restriction sites) 
(Shetty et al., 2008). However, the highlighted standardization is only limited to the 
assembly method, and does not encompass functional characteristics of each part, e.g., 
promoter strength. As a result, judicious choice of a promoter remains a challenging 
task, especially when a well-defined expression level is desired.  
The main obstacle to standardization of promoters and its activity is biological 
complexity. Most often than not, whenever a new promoter is discovered or engineered, 
its activity is determined indirectly, by measuring expression level of a reporter protein, 
e.g., green fluorescence protein (GFP). However, very frequently such a result is not very 
reliable as protein expression level is not only dependent on the rate of transcription 
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initiation but also on a myriad of different factors (Figure 7). As a result, the reported 
protein expression level can be reproduced only when all the other parameters remain 
the same, e.g., amount of produced protein will increase when a plasmid with a higher 
copy number is used. Furthermore, there are significant differences in the accuracy of 
various methods of protein expression quantification. For example, measuring protein 
activity (e.g., fluorescence of GFP) usually does not provide any information about the 
amount of insoluble protein present in the cell – the in-depth comparison of T7, trc and 
lacUV5 promoters showed that lacUV5, the weakest promoter among the three, 
produces the highest fraction of soluble protein (Tegel et al., 2011).  In a similar study, 
five expression systems (Lacl/PT7, Lacl/Ptrc, AraC/PBAD, XylS/Pm and XylS/Pm ML1-17) 
were compared using a variety of different methods, including mRNA quantification, 
activity measurements, polyacrylamide gel electrophoresis and flow cytometry (Balzer et 
al., 2013). T7 promoter was confirmed to produce the highest amount of RNA 
transcript, which resulted in a correspondingly high production of insoluble protein. In 
addition to providing invaluable information about the five promoter systems, the study 
brought attention to the differences in protein expression between individual cells, 
indicating differences in culture homogeneity between the investigated promoter 
systems. 
An important milestone in standardization of bacterial promoters and its activity has 
been the introduction of Relative Promoter Unit (RPU) (Kelly et al., 2009). In their 
research paper, Kelly et al. argue that the most representative and unbiased indicator of 
promoter activity is the rate of transcription initiation. Accurate determination of 
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absolute transcription initiation rate proves to be very challenging, if not impossible, and 
as a result its usefulness for describing promoter activity had been limited for a long 
time. It is shown, however, that under right experimental conditions relative rate of 
transcription initiation is approximated by the ratio of GFP synthesis rates of two 
promoters, the quantity that can be fairly easily determined experimentally. By 
measuring promoter activity relative to a standard promoter (BBa_J23101 in this case), 
the variation in the obtained results can be reduced by about 50%. As a result, the 
concept of RPUs allows for a more reliable comparison between different promoters and 
paves the way for comprehensive standardization of bacterial promoters. 
1.4.8 Complementary technologies and future prospects 
Regulation of transcription initiation is certainly not the only method of influencing the 
protein expression level. Modulating mRNA stability has been, for quite some time, one 
of the strategies of engineering gene expression (Carrier and Keasling, 1997, 1999; Gao 
et al., 2012; Smolke et al., 2000). Similar to promoters, ribosome binding sites (RBSs) 
can be designed to provide a specified rate of mRNA translation and, consequently, 
protein expression; in addition, based on thermodynamic calculations the strength of 
RBSs can be predicted in silico (Salis et al., 2009). Another approach, which allows for 
fine-tuning of gene expression, involves engineering of intergenic regions within a single 
operon - various post-transcriptional control elements were recombined and screened for 
desired expression, leading to 100-fold variation in the relative expression levels (Pfleger 
et al., 2006). Methods utilizing protein scaffolds (Dueber et al., 2009) and riboswitches 
(Topp et al., 2010) were also reported. Despite a great variety of presented strategies, 
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promoter selection still remains an integral part of these experiments and, as a result, 
advances in promoter engineering are still driving the development of genetic 
engineering and biotechnology. Additionally, the highlighted methods of modulating 
protein expression should be perceived as being complementary to promoter engineering 
rather than being in a direct competition to one another.  
Judging by the variety of recombinant proteins produced using prokaryotic organisms 
and the diverse applications of bacterial promoters in the emerging fields of biological 
research, it would be unwise to assume that a single expression system, robust and 
versatile enough to meet all demands of the scientific community, will be constructed in 
the near future. It is much more plausible that the rapid expansion of promoter 
engineering (Blazeck and Alper, 2013), accelerated by the developments in the high-
throughput screening technologies (Paul et al., 2013), will provide us with an 
abundance of bacterial promoters with unique characteristics. As the number of available 
expression systems is expected to rise continually, it is imperative that promoter selection 
procedures are expedited and streamlined by further developing enabling bioinformatics 
tools, expanding existing databases, and adopting a unified method of measuring and 
quantification of promoter activity. Only then, the key goal of synthetic biology – 
construction of functional and well-defined biological systems from standardized 
biological components – can be fully realized. 
  
  
 
| 84 | 
1.5 Genetic diversity and interactions between multiple 
genes 
The review of genetic diversity has been, so far, limited to the discussion of single 
genetic elements. However, many phenotypes are encoded by multiple genes. For 
example, an ability to produce certain chemicals of commercial value is often encoded 
by vast metabolic pathways, spanning a whole host of closely-regulated genes. Intrinsic 
resistance of certain microorganisms to harsh environmental conditions  - e.g., extreme 
temperature – can be attributed to the expression of more than one gene. What is more, 
the genes responsible for a particular phenotypes does not necessarily have to be located 
next to each other and might be located within distant genetic loci. This phenomenon 
significantly limits the usability of traditional function-based metagenomics when it 
comes to identifying genes encoding for complex phenotypes as only one DNA 
fragment can be screened at a time. 
As a result, in order to be able to efficiently engineer the whole organisms, another 
approach is needed. Traditionally, this has been achieved through, so called, classical 
strain improvement. In this approach, organisms of interest is subjected to the action of 
physical or chemical mutagens (e.g., UV radiation) and constant selective conditions 
(e.g., increasing temperature), which depend on a specific phenotype that is being 
evolved or improved on. Despite its widespread use, the method is often very time-
consuming and resource-intensive. Additionally, many mutations unrelated to the 
targeted phonotype are introduced in the process. The scale and precise nature of these 
genetic changes are often unknown, frequently leading to creation genetically-unstable 
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organisms. Finally, the use of harmful mutagens is also a major drawback that raises 
serious health and safety concerns. 
To circumvent the addressed shortcomings, in recent years, novel methods allowing for 
simultaneous alteration of multiple genetic elements have been created to eventually 
provide a more robust way of identifying genes encoding for useful phenotypes and 
evolving organisms with desired properties. The reported methods can be broadly 
classified into three main groups depending on the utilised mechanism (Tee and Wong, 
2014): 
(1) DNA shuffling 
(2) copy number 
(3) transcription factors 
(4) regulatory elements (e.g., promoters and ribosomal binding sites) 
A representative example of the first group is whole-genome shuffling reported by 
Zhang et al (Zhang et al., 2002). The usefulness of the presented method was 
demonstrated by obtaining 9-fold increase in tylosin production by actinobacteria 
Streptomyces fradiae.  
Chemically inducible chromosomal evolution (CIChE) is a copy-number-based method 
that utilises E. coli recA homologous recombination to create and screen bacterial cells 
containing different of gene copy number on their chromosomes (Tyo et al., 2009). The 
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use of the reported method led to obtaining 4-fold increase in biopolymer poly-3-
hydroxybutyrate production and 10-fold increase in genetic stability.  
Another novel approach to evolving useful traits involves engineering of prokaryotic 
transcription factors, e.g., the  E. coli main sigma factor,  σ70 (Alper and Stephanopoulos, 
2007). Random mutagenesis of rpoD, encoding for σ70, alters the promoter preferences 
of RNA polymerase and allows for identification of E. coli cells exhibiting abnormal 
phenotypes. Global transcription machinery engineering (gTME) was shown to be 
successful at evolving lycopene overproduction and increased tolerance to ethanol.  
Finally, multiplex automated genome engineering (MAGE) targets many locations on a 
bacterial chromosome via the use of degenerate oligonucleotides (Wang et al., 2009b). 
Oligonucleotide-mediated sequence replacement can be used to target both genes and 
regulatory elements. Targeting of ribosome binding sites allowed for optimization of the 
1-deoxy-d-xylulose-5-phosphate (DXP) biosynthesis pathway in E. coli and obtaining a 
5-fold increase in lycopene production. It is worth noting that the whole experimental 
procedure was fully automated. On the other hand, trackable multiplex recombineering 
(TRMR) uses synthetic DNA cassettes to replace endogenous promoters or ribosome 
binding sites (Warner et al., 2010). This strategy, in combination with utilisation of 
molecular barcoding and microarrays, led to mapping of E. coli genes that confer growth 
advantage in various media and in the presence of several growth inhibitors.  
Despite the great variety of the presented methods, their widespread use is 
frequently hindered by the complex protocol and high operating costs. One of the few 
methods offering a relatively simple workflow is based on Coexisting/Coexpressing 
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Genomic Libraries, CoGeLs, (Nicolaou et al., 2011). In this method, fragmented 
genomic DNA from an organism of interest is fragmented and transferred into 
individual plasmids (or fosmids) and, in contrast to standard genomic libraries, two 
plasmids are transformed into each cell (via two consecutive transformations). Both 
plasmids can normally coexist in the same cell as they contain different origins of 
replication. This approach allows for identification of interactions between distant 
genetic loci. As a proof of concept, the method has been used to identify genes encoding 
for complex acid-tolerance phenotype in E. coli and lead to identification of the novel 
combination of arcZ and recA genes that enhanced acid tolerance by 9000-fold 
(confirming that complex phenotypes such as acid tolerance can be encoded two-genes 
combinations). 
 Despite its great potential, the presented method is not free from inherent 
drawbacks. Necessity of two successive transformations considerably increases the 
complexity and duration of the whole method, and decrease its reliability (a significant 
fraction of screened cells is likely to contain more than two plasmids). Moreover, despite 
major advances in our understanding of regulatory elements and genetic circuits, they 
have not been used extensively in the area of multiple gene alterations. Finally, all the 
methods reported concentrate on altering genes, or their expression, that are native to 
the evolved organism. So far, there has been no major attempts to combine genetic 
information from other organisms – for example, utilising chromosomal DNA of 
thermophilic bacteria to evolve thermostability in common bacterial strains. 
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1.6 Scope and objectives  
The aim of this thesis is to expand molecular toolbox for synthetic biology and allow a 
more efficient access to largely untapped potential of biological diversity. By reviewing 
the current landscape of synthetic biology and various methods of tapping into 
biodiversity, I identified two high-impact areas that are particularly lacking and, as such, 
constitute the focal point of my PhD project. 
Gene cloning is a basic molecular technique that constitutes an important part of nearly 
every complex experiment associated with genetic engineering and is used extensively in 
research laboratories around the world. The impact of molecular cloning is particularly 
evident in areas such as protein engineering where, on many occasions, it is a major 
bottleneck to the process of directed evolution. Consequently, its performance is 
detrimental the rate with which new biological parts are discovered. Furthermore, faster 
and simpler molecular cloning techniques would address the issue of biological 
complexity, one of the main challenges of synthetic biology (Kwok, 2010), by 
facilitating the process of constructing and testing new biological circuits. As such, 
despite its seemingly simple concept, the importance of molecular cloning is paramount. 
To address this problem, I aim to build upon recent advances in gene cloning and 
molecular biology, in general, to develop a relatively simple, fast and efficient method of 
integrating a DNA fragment of interest into an expression vector of choice. If possible, 
this strategy should also be applicable to cloning of combinatorial libraries and its 
usefulness to various branches of synthetic biology – including, but not limited to, 
protein engineering - should be clearly demonstrated. 
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The second high-impact area to be indentified is the field of microbial strain 
improvement and identifying genes encoding for complex phenotypes. In recent years, 
many novel methods for simultaneous alterations of multiple genes have been created to 
advance the progress of this area of research. The reported methods aim at improving 
biological organisms via a variety of different methods such as DNA shuffling, 
modification of gene copy number or utilisation of either transcription factors or 
regulatory elements such as promoters and ribosome binding sites. Unfortunately, most 
of the reported techniques are very complex and resource intensive, considerably 
limiting their general applicability.  
To address the discussed shortcomings, I aim to expand the concept of genomic libraries 
to allow for a more robust way of identifying genes encoding for useful phenotypes and 
evolving microorganisms with desired properties. The functionality of the method 
should be proven by evolving a useful phonotype – e.g., halotolerance or 
thermotolerance – in an industrially-relevant bacterial species, such as Escherichia coli. 
If successful, this PhD project should expand molecular toolbox available to synthetic 
biologists and enhance the way biodiversity – both natural and laboratory-induced – is 
being studied and utilised. 
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Chapter 2 
 
QuickStep-Cloning 
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This chapter has been adapted from: 
Jajesniak P, Wong TS. (2015) QuickStep-Cloning: a sequence-independent, ligation-free 
method for rapid construction of recombinant plasmids. Journal of Biological Engineering, 
9, 15 
2.1 Abstract 
Background: Molecular cloning is an essential step in biological engineering. Methods 
involving megaprimer-based PCR of a whole plasmid are promising alternatives to the 
traditional restriction-ligation-based molecular cloning. Their widespread use, however, 
is hampered by some of their inherent characteristics, e.g., linear amplification, use of 
self-annealing megaprimers and difficulty with performing point insertion of DNA. 
These limitations result in low product yield and reduced flexibility in the design of a 
genetic construct. 
Result: Here, we present a novel technique of directional cloning, which overcomes 
these problems yet retaining the simplicity of whole-plasmid amplification. QuickStep-
Cloning utilizes asymmetric PCRs to create a megaprimer pair with 3’-overhangs, and 
hence, facilitates the subsequent exponential whole-plasmid amplification. QuickStep-
Cloning generates nicked-circular plasmids, thereby permitting direct bacterial 
transformation without DNA ligation. It allows DNA fragment integration into any 
plasmid at any position, in an efficient, time- and cost-effective manner, without tedious 
intermediate DNA gel purification, modified oligonucleotides, specialty enzymes and 
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ultra-competent cells. The method is compatible with competent E. coli cells prepared 
using the conventional calcium chloride method.   
Conclusion: QuickStep-Cloning expands the versatility of megaprimer-based cloning. 
It is an excellent addition to the cloning toolbox, for the benefit of protein engineers, 
metabolic engineers and synthetic biologists.   
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2.2 Background 
Gene cloning is an indispensable molecular biology technique that, since its first 
introduction, has been central to the development of genetic engineering and, 
consequently, the entire field of life sciences. Despite its widespread use, the traditional, 
restriction-ligation-based cloning protocol suffers from major problems, including, but 
not limited to: (i) low efficiency, (ii) dependency on the availability of unique restriction 
sites in a cloning vector and in the gene of interest, and (iii) time-consuming and 
labour-intensive process. In recent years, many novel approaches to molecular cloning 
have been proposed to expedite the procedure, enhance cloning efficiency and bypass 
the requirement of restriction sites (Lu, 2005; Tee and Wong, 2013). Homologous 
recombination (Court et al., 2002; Zhu et al., 2010), incorporation of phosphorothioate 
oligonucleotides (Blanusa et al., 2010) and use of zinc finger nucleases (Shinomiya et al., 
2011) are only a few examples of different strategies utilized for this purpose.  
Among the reported approaches to DNA cloning, methods involving megaprimer-based 
PCR of a whole plasmid, e.g., restriction site-free cloning (Chen et al., 2000), 
restriction-free (RF) cloning (van den Ent and Lowe, 2006), overlap extension PCR 
cloning (Bryksin and Matsumura, 2010) and MEGAWHOP cloning (Miyazaki, 2011), 
have attracted a significant interest among the scientific community. These methods 
were inspired by the hugely popular and easy-to-use QuikChangeTM (Agilent) protocol 
for site-directed mutagenesis (Life Technologies, 2017). Despite their indisputable 
potential, megaprimer-based methods are inherited with several drawbacks that 
compromise their overall efficiency: (i) linear amplification of the recipient vector, (ii) 
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use of a completely complementary megaprimer pair, (iii) difficulty with performing 
point insertion of DNA, (iv) random mutations introduced by the DNA polymerase of 
choice during whole-plasmid amplification, and (v) poor amplification of GC-rich DNA 
fragments. The listed drawbacks significantly decrease the overall efficiency of the 
cloning method and, consequently, necessitate the use of enzyme-based DNA ligation 
and time-consuming optimisation of PCR conditions to achieve a sufficient number of 
transformants containing recombinant DNA of interest. Four recently proposed cloning 
methods, asymmetric bridge PCR with intramolecular homologous recombination 
[ABI-REC, (Bi et al., 2012)], recombination-assisted megaprimer (RAM) cloning 
(Mathieu et al., 2014) exponential megaprimer PCR (EMP) cloning (Ulrich et al., 
2012), and inverse fusion PCR cloning [IFPC, (iGEM)], have been reported to achieve 
exponential amplification via incorporating additional oligonucleotides into megaprimer 
PCR. In all cases, however, the amplification results in generation of linearized plasmids 
instead of the more desirable circular DNA. ABI-REC and RAM are homologous 
recombination-dependent methods, relying on transformation of linearized plasmids 
and their repair in vivo, which usually provides significantly less transformants than 
transformation of nicked or intact plasmids. On the other hand, EMP and IFPC 
cloning protocols require phosphorylation and ligation to circularize the amplification 
products.  
Here, we report QuickStep-Cloning, a novel method that builds upon the simplicity of 
QuikChangeTM. Not only it addresses major drawbacks of traditional DNA cloning, the 
method also circumvents the aforementioned problems of the existing megaprimer-
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based cloning methods, including the problem of linear amplification and self-annealing 
megaprimers. 
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2.3 Results and Discussion 
2.3.1 QuickStep-Cloning: Principle and molecular mechanism 
In QuickStep-Cloning, DNA fragment of interest is amplified in two parallel 
asymmetric PCRs (Wang et al., 2009a), during which regions complementary to the 
integration site on the recipient plasmid are added to both ends of the amplified DNA 
fragment (Figure 2.1).  
 
Figure 2.1  Overview of QuickStep-Cloning: (A) A schematic diagram presenting 
individual stages involved in the proposed method: (1) two parallel 
asymmetric PCRs of DNA of interest and PCR purification, (2) 
megaprimer-based PCR, (3) DpnI digestion, and (4) bacterial 
transformation. (B) Exemplary workflow for 1 kb insert and 7 kb 
cloning vector (exact duration of the asymmetric PCR depends on the 
length of cloned DNA fragment and the duration of megaprimer PCR is 
related to the size of the cloning vector). (C) Outline of exponential 
(1)
(1)
3’
3’ (3) (4)
Asymmetric PCR
1 h
PCR purification
30 min
Megaprimer PCR
2 h
DpnI digestion
15 min
Transformation
1.5 h (or less)
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B
(2) (2)
...
C
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amplification taking place during QuickStep-Cloning – megaprimers 
anneal themselves to the product of linear amplification and are 
extended by polymerase, producing further copies of the two single-
stranded templates in an exponential manner.  It should be noted that 
for the given mechanism, exponential amplification occurs in parallel 
with the linear process. 
The products of the two asymmetric PCRs are purified, mixed and used as megaprimers 
for the consecutive PCR. In contrary to the traditional megaprimer-based PCR of a 
whole plasmid, the megaprimer pair in QuickStep-Cloning contains 3’-overhangs 
(instead of blunt ends) allowing it to anneal to the recipient plasmid even when the two 
megaprimers self-anneal. Megaprimers designed in this way facilitate an exponential 
amplification, which results in production of nicked-circular plasmids. After a short 
incubation with DpnI to remove methylated/hemimethylated recipient plasmids that do 
not contain gene of interest, the product of the megaprimer PCR can be directly used 
for transformation. For a 1-kb gene and a 7-kb recipient plasmid, for instance, the entire 
workflow can be completed in less than 6 hours (Figure 2.1).  
2.3.2 Primer design for QuickStep-Cloning 
QuickStep-Cloning allows point integration of a gene at any position of any recipient 
plasmid. This is achieved through judicious design of the four primers (denoted as Fwd, 
Rev, IntA-Fwd and IntB-Rev, Figure 2.2) that are used in the two parallel asymmetric 
PCRs. Fwd and Rev are primers derived from the target gene sequence only (18−22 bp). 
IntA-Fwd and IntB-Rev, are chimeric primers, carrying both the sequence upstream or 
downstream to the integration site and the target gene sequence (46−48 bp). 
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Asymmetric PCR with unbalanced concentration of Fwd (500 nM) and IntB-Rev (10 
nM) primers results in sense strands with integration sequence at 3’-termini. Likewise in 
another asymmetric PCR using 10 nM of IntA-Fwd and 500 nM of Rev, antisense 
strands with integration sequence at 3’-termini are produced. When both strands from 
the two asymmetric PCRs are purified and mixed, megaprimer pairs with 3’-overhangs 
are produced for use in the subsequent megaprimer PCR step.  
 
 
Figure 2.2 Outline of primer design for QuickStep-Cloning. The sequences of Fwd 
and Rev primers are derived from the target gene sequence. IntA-Fwd 
and IntB-Rev are chimeric primers, carrying sequence of integration site 
(5’-portion) and target gene sequence (3’-portion). 
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2.3.3 Demonstration of QuickStep-Cloning 
To investigate the efficiency of the proposed design, QuickStep-Cloning was utilized to 
transfer a DNA fragment from pEGFP vector (containing ampicillin resistance gene; 
Figure 2.3) into pET24a-HLTEV-p53 plasmid (containing kanamycin resistance gene). 
The primers were designed to perform a point insertion of egfp gene just before the p53 
open reading frame (Figure 2.4), producing kanamycin-resistant transformants capable 
of EGFP expression. After 30 cycles of asymmetric PCR and 25 cycles of megaprimer 
PCR, E. coli strains DH5α and C41 (DE3) were transformed with 5 µl of DpnI-
digested PCR product and plated on agar plates supplemented with ampicillin or 
kanamycin and IPTG (Table 2.1).  
Table 2.1  Results of egfp cloning experiment. Colony counts for E. coli strains 
DH5α and C41 (DE3) transformed with the products of RF cloning 
and of QuickStep-Cloning and plated on agar plates supplemented with: 
(i) 100 µg/ml ampicillin, (ii) 50 µg/ml kanamycin, and (iii) 50 µg/ml 
kanamycin and 1 mM IPTG. Transformation efficiency was determined 
based on concurrent transformation of 1 ng intact pET24a-HLTEV-p53 
plasmid. Numbers in the brackets denote EGFP-expressing colonies, as 
determined by visual inspection using UV transilluminator. Lack of 
colonies observed on ampicillin-supplemented agar plates indicated  that 
the final PCR mixture produced via QuickStep-Cloning, used directly 
for bacterial transformation, did not contain significant amount of donor 
plasmid. 
Strain, Selection plate QuickStep-Cloning RF Cloning 
Transformation 
efficiency [cfu/µg] 
DH5α, Ampicillin 0 0 3.8·104 
DH5α, Kanamycin 476 35 3.8·104 
C41(DE3), Kan+IPTG 618(575) 160(7) 4.2·106 
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Figure 2.3  Plasmid map of pEGFP vector used in egfp cloning experiment (created 
with SnapGene). 
 
Figure 2.4  Outline of egfp gene cloning experiment. (A) Product of two asymmetric PCRs 
– egfp gene with 3’ overhangs corresponding to the annealing sites flanking 
DNA insertion point present in pET24a-HLTEV-p53. (B) Sequence of the 
two megaprimer annealing sites. 
…CACCGGCGAAAACCTGTACTTCCAGGGTGGATCC ATGGAGGAGCCGCAGTCAGATCCTAGCGTCGA…
…GTGGCCGCTTTTGGACATGAAGGTCCCACCTAGG TACCTCCTCGGCGTCAGTCTAGGATCGCAGCT…
A
B
pET24a-HLTEV-p53
EGFP gene
3’
3’
Gene insertion point
3’
3’
Annealing site 1 Annealing site 2 
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EGFP-expressing colonies were easily discernible for C41 (DE3) grown on IPTG-
supplemented plates (Figure 2.5). The accuracy of visual inspection of the transformants 
has also been further verified, by selecting randomly five EGFP-negative colonies and 
growing them at 30°C for 24 h in TB-based auto-induction media – no fluorescence was 
detected for all five clones (Figure 2.6). Worthy of note, there is no need to first remove 
p53 gene that is pre-cloned into the recipient vector, highlighting a useful feature of 
QuickStep-Cloning. Further, the product of QuickStep-Cloning can be directly 
transformed into an expression strain [such as C41 (DE3)] for protein expression, 
bypassing the intermediate cloning strain (DH5α). Plasmids from ten randomly selected 
EGFP-expressing colonies were sequenced and the presence of DNA insert in the 
recombinant pET24a-HLTEV-p53 has been confirmed for all 10 clones. Worthy of 
note, no undesired mutation was found within the egfp gene in any of the 10 clones. In 
9 cases, egfp gene was inserted at desired position in the right orientation. One plasmid 
contained two copies of egfp gene separated by a 28 bp sequence, containing partial 
sequence of IntA-EGFP-Fwd and IntB-EGFP-Rev primers. This construct is, most likely, 
a result of megaprimer-dimer formation during whole plasmid amplification. 
Concurrently, plasmids from five EGFP-negative colonies were sequenced – one clone 
contained no insert and the remaining four carried unwanted mutations in egfp gene. 
Three of them contained single base substitutions. One contained three single base 
substitutions and one 3 bp deletion, all present in the region where primers EGFP-Fwd 
or IntA-EGFP-Fwd bind.   
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Figure 2.5  Photograph of E. coli C41 (DE3) colonies formed on agar plates 
supplemented with 50 µg/ml kanamycin and 1 mM IPTG after being 
transformed with the product of QuickStep-Cloning (as part of egfp 
cloning experiment). EGFP-expressing colonies are easily discernible 
even under visible light. 
 
 
Figure 2.6  Cell pellets from cell cultures grown as part of egfp cloning experiment. 
Five EGFP-negative colonies together with one EGFP-expressing colony 
and one colony containing original pET24a-HLTEV-p53 were picked 
randomly and used to inoculate separate 5 ml aliquots of TB-based auto-
induction media. After 24 h incubation at 30°C, 3 ml aliquots of cell 
culture were spun down and the resultant cell pellets were visually 
inspected for EGFP expression. 
EGFP(-) colonies 
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2.3.4 Optimizing QuickStep-Cloning 
The success of QuickStep-Cloning is attributed to our ability to produce (1) ssDNA in 
sufficient quantity in the two asymmetric PCRs, and (2) high yield of megaprimer PCR. 
To address the former, the primer ratio in asymmetric PCRs (i.e., the ratio of Fwd-IntA 
to Rev and the ratio of Rev-IntB to Fwd) was optimized (Figure 2.7).  
 
Figure 2.7  Investigation and optimization of asymmetric PCR stage of QuickStep-
Cloning. (A) Yield of two parallel asymmetric PCRs for different primer 
ratios (represented by two separate rows for each ratio). (B) 
Identification of single stranded product of asymmetric PCR stage – (1) 
individual products of two parallel asymmetric PCRs, (2) both products 
after 2 min denaturation at 94°C, (3) renatured products, and (4) 
products of two parallel asymmetric PCRs after being mixed together. In 
all gel pictures, the appearance of low and high molecular weight bands 
could be attributed to non-specific binding of primers, commonly seen 
in regular PCRs.  
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Figure 2.8  Yield of whole plasmid amplification for different primer ratios used 
during asymmetric PCRs.  
At a ratio of 1:1, the PCR product was predominantly dsDNA, which was excellently 
stained by Diamond Nucleic Acid Dye from Promega (Figure 2.7A). At ratios of 1:20, 
1:50 and 1:100, a lower gel band corresponding to ssDNA product started to appear. 
ssDNA migrates faster in agarose gel compared to its dsDNA counterpart and is less 
efficiently stained by fluorescent dye. A series of denaturation and annealing experiments 
were conducted (Figure 2.7B), confirming the identity of these lower gel bands. The 
effect of primer ratio on the efficiency of the proposed cloning method has further been 
investigated by analyzing subsequent whole plasmid amplification (Figure 2.8) and, 
based on the results obtained, 1:50 ratio was concluded to be the most optimal. To 
← recombinant 
plasmid
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obtain good product yield in megaprimer PCR, three parameters were carefully 
optimised, namely number of PCR cycles, concentration of recipient plasmid and 
megaprimer concentration (Figure 2.9). 
 
Figure 2.9  Optimization of megaprimer PCR stage of QuickStep-Cloning. (A) 
Yield of megaprimer PCR for varying number of PCR cycles. (B) Yield 
of megaprimer PCR for different concentrations of recipient plasmid. 
(C) Yield of megaprimer PCR for different concentrations of 
megaprimer. In all gel pictures, the appearance of low and high 
molecular weight bands could be attributed to non-specific binding of 
primers, commonly seen in regular PCRs.  
2.3.5 Comparison to restriction-free (RF) cloning 
To demonstrate the superior performance of QuickStep-Cloning, restriction-free (RF) 
cloning was carried out in parallel for comparison, using identical reaction conditions 
and primer design. QuickStep-Cloning provided much higher number of transformants 
- 93% of which contained recombinant plasmid (Table 2.1). RF cloning provided 160 
transformants, only 4% of which displayed fluorescence. Five out of only seven EGFP-
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expressing colonies obtained via RF cloning were used for subsequent sequencing – four 
plasmids contained the desired insert at the right orientation. One of the plasmids 
included not only a single mutation within the egfp gene but also an additional long 
(>100 bp) DNA fragment located between egfp and p53 genes, containing partial 
sequence of IntA-EGFP-Fwd and IntB-EGFP-Rev primers. Poor efficiency of RF cloning 
might be attributed to lack of DNA ligation and, most importantly, inherent difficulties 
with point insertion of DNA, characteristic to many cloning methods relying on 
megaprimer-based PCR of a whole plasmid. Important to note, in the case of RF 
cloning it is advised to have a distance of 50 to several hundred base pairs between the 
two annealing sites on the recipient plasmid (Bryksin and Matsumura, 2010), 
necessitating removal of a short DNA sequence between both annealing sites during 
cloning. Sequencing 5 plasmids isolated from EGFP-negative colonies showed that three 
of them contained a relatively short (~30 bp) DNA insert instead of a desired egfp gene, 
plausibly a result of mispriming and primer-dimer formation. The remaining two did 
not return readable sequence.  
2.3.6 General applicability of QuickStep-Cloning  
QuickStep-Cloning is not limited to transfer of gene between two plasmids carrying 
distinct selection markers (in the case of egfp cloning, gene was transferred from Ampr-
pEGFP to Kanr-pET24a-HLTEV-p53). To investigate the robustness of the developed 
protocol, QuickStep-Cloning method was applied to another system. The rfp gene from 
Kanr-pBbA8k-RFP (containing rfp gene, under the control of arabinose-inducible 
promoter; Figure 2.10) was successfully cloned into Kanr-pET24a-HLTEV-p53 using  
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Figure 2.10  Plasmid map of pBbA8k-RFP vector used in rfp cloning experiment 
(created with SnapGene). 
 
Table 2.2  Results of rfp cloning experiment. Colony counts for E. coli strains 
DH5α and C41 (DE3) transformed with the products of RF cloning 
and of QuickStep-Cloning and plated on agar plates supplemented with: 
(i) 50 µg/ml kanamycin and (ii) 50 µg/ml kanamycin and 1 mM IPTG. 
Transformation efficiency was determined based on concurrent 
transformation of 1 ng intact pET24a-HLTEV-p53 plasmid. Numbers 
in the brackets denote RFP-expressing colonies, as determined by visual 
inspection of the plates. 
Strain, Selection plate QuickStep-Cloning RF Cloning 
Transformation 
efficiency [cfu/µg] 
DH5α, Kanamycin 334 26 3.8·104 
C41(DE3), Kan+IPTG 418(404) 113(103) 4.2·106 
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QuickStep-Cloning. The only differences in the protocol from egfp cloning experiment 
have been the use of a new set of four primers, designed following general guidelines 
presented in this paper, and the corresponding annealing temperatures. Without any 
further optimization, QuickStep-Cloning again exhibited superior performance in 
comparison to RF cloning (Table 2.2), providing 418 colonies, 97% of which expressed 
RFP (Figure 2.11).  
 
Figure 2.11  Photograph of E. coli C41 (DE3) colonies formed on agar plates 
supplemented with 50 µg/ml kanamycin and 1 mM IPTG after being 
transformed with the product of QuickStep-Cloning (as part of rfp 
cloning experiment). RFP-expressing colonies are easily discernible 
under visible light. 
The accuracy of visual inspection of agar plates has been confirmed by further expression 
studies (Figure 2.12 and 2.13). Sequencing has shown that out of five investigated RFP-
expressing transformants, all five of them contained pET24a vector with rfp insert. Only 
one clone contained unwanted mutation, namely, a 5-bp deletion downstream of egfp 
gene (i.e., at the vector integration site). Interestingly, plasmids from five out of only 15 
observed RFP-negative colonies have also been scrutinized and all of them had short 
RFP(-) colonies 
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deletions at or close to start codon of rfp gene, where primers RFP-Fwd or IntA-RFP-
Fwd bind. The localization of these unwanted mutations within the primer-binding 
region is unlikely to be purely coincidental. It is hypothesized that these artifacts could 
be derived from the impurities (e.g., deletion products) present in the synthetic 
oligonucleotides. As the occurrence of occasional mutations, especially deletions, is a 
widely-known shortcoming of long, desalted primers, it is envisaged that the use of 
HPLC-purified primers can further improve the already exceptionally high efficiency of 
QuickStep-Cloning.  
 
 
Figure 2.12  Cell pellets from cell cultures grown as part of rfp cloning experiment. 
One RFP-expressing colony together with one RFP-negative colony and 
one colony containing original pET24a-HLTEV-p53 were picked 
randomly and used to inoculate separate 5 ml aliquots of 2×TY media 
supplemented with 1 mM IPTG. After 48 h incubation at 30°C, 3 ml 
aliquots of cell culture were spun down and the resultant cell pellets were 
visually inspected for RFP expression. 
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Figure 2.13  Cell pellets from cell cultures grown as part of rfp cloning experiment. 
Three RFP-expressing colonies were picked randomly and used to 
inoculate separate 5 ml aliquots of 2×TY media. One sample contained 
media only (1), one was supplemented with 1 mM IPTG (2) and 
0.1% w/v arabinose was added to the remaining one (3). After 48 h 
incubation at 30°C, 3 ml aliquots of cell culture were spun down and the 
resultant cell pellets were visually inspected for RFP expression. 
 
2.3.7 Comparison to other cloning methods 
In order to highlight the novelty of and the benefits offered by QuickStep-Cloning, the 
proposed method was compared with four recently reported strategies of exponential 
megaprimer-based cloning (ABI-REC, RAM cloning, EMP cloning and IFPC); the 
results of this comparison are summarized in Table 2.3. QuickStep-Cloning is one of 
the first cloning methods fully optimised for use with the recently developed Q5 High-
Fidelity DNA Polymerase (New England Biolabs), which is characterised by its ultra-
low error rate (200× higher fidelity than Taq polymerase and approximately 2× higher 
fidelity than the widely-used Phusion polymerase), very high speed of DNA replication
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Table 2.3  A comparison of QuickStep-Cloning to other recently reported megaprimer-based cloning methods. Desirable features are highlighted 
in orange to facilitate comparison.  
Cloning method QuickStep-Cloning RF ABI-REC RAM EMP IFPC 
Cloning strategy Megaprimer Megaprimer Megaprimer Megaprimer Megaprimer Megaprimer 
Amplification mode Exponential Linear Exponential Exponential Exponential Exponential 
Transformed product 
Nicked-circular 
plasmid (2 nicks per 
plasmid) 
Nicked-circular 
plasmid (2 nicks per 
plasmid) 
Linear DNA Linear DNA 
Closed-circular 
plasmid 
Closed-circular 
plasmid 
E. coli cells used 
Chemically competent 
DH5α and C41 
(DE3) 
Electrocompetent TG1 
Chemically competent 
DH5α 
Strain type not 
reported 
Chemically competent 
DH5α 
 Chemically competent 
TOP10 
In vivo homologous 
recombination 
No No Yes Yes No No 
Enzymatic 
phosphorylation-
ligation 
No No No No Yes Yes 
Number of primers 
required 
4 2 3 3 3 3 
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Gel purification No No No 1× No Strongly recommended 
PCR purification 1× 1× No No 2× No 
Estimated cloning 
time1 
5 h 15 min 14 h 7 h 45 min 7 h 45 min 7 h 15 min 6 h 30 min 
Reported cloning 
efficiency 2 
93-97% ~90% 3 93–100% 75-94% 10–100% ~90% 
Reference - (van den Ent and Lowe, 2006) (Bi et al., 2012) 
(Registry of Standard 
Biological Parts) (Ulrich et al., 2012) (iGEM) 
 
1As estimated for cloning 1 kb DNA fragment into 7 kb plasmid according to originally reported protocol (for more information see Additional documentation). 
2 Judging by the percentages reported, all methods are capable of delivering similar efficiency. Worthy of note, these numbers are dependent on the approaches used by the authors 
to evaluate cloning efficiency.  
3 As reported in the original paper (van den Ent and Lowe, 2006). Ulrich et al. (Ulrich et al., 2012) and Mathieu et al. (Registry of Standard Biological Parts) demonstrate, 
respectively, 27% and 16% efficiency for RF cloning.  
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(6 kb/min) and superior performance for a broad range of amplicons, including DNA 
with a high GC content. The presented method was demonstrated to be suitable for 
direct transformation of not only widely used E. coli cloning strain (DH5α) but also a 
common expression strain, C41 (DE3). Worthy of note, the two distinct experiments 
utilizing QuickStep-Cloning (cloning of egfp and rfp genes) provided hundreds 
transformants (Table 2.1 and 2.2), despite the use of a relatively simple transformation 
method (allowing for transformation efficiencies in the range of just 104-106 cfu per µg 
of intact plasmid). In comparison, many of the previously-reported methods were 
investigated based solely on highly-efficient transformation protocols. For example, 
overlap extension PCR cloning, a method utilizing the principles of RF cloning, was 
reported to produce up to 600 colonies from small aliquots of final PCR mixture 
(Bryksin and Matsumura, 2010). However, the chemically competent E. coli cells used 
in that study had been prepared via Inoue method, a time-consuming protocol which 
allows to achieve transformation efficiencies exceeding 109 cfu/µg (Wong et al., 2004a).  
In stark contrast to the other four recently reported methods, QuickStep-Cloning does 
not rely on either undesirable in vivo homologous recombination or enzymatic 
phosphorylation-ligation process. The whole cloning procedure requires only one PCR 
purification step, whereas both RAM cloning and IFPC involve time-consuming gel 
purification. Based on a rough estimate of time needed to integrate a 1-kb DNA 
fragment into a 7 kb plasmid using the six different megaprimer-based cloning methods, 
QuickStep-Cloning emerges as an unquestionable winner when it comes to overall 
cloning time. Most importantly, its cloning efficiency compares favourably to the values 
reported for the remaining five methods. The only drawback of QuickStep-Cloning is 
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its requirement of four distinct primers (difference of one additional short primer in 
comparison to the other exponential cloning methods). Even though there is a chance of 
accidental DNA misinsertion (no such cases have yet been identified throughout our 
study), Fwd and Rev primers can be useful in colony PCR for quick identification of 
plasmids with gene insert. Of course, the use of primers complementary to vector 
regions flanking the insertion site is most appropriate for identifying clones with gene 
inserted at desired location. 
Based on the presented facts, QuickStep-Cloning fares exceptionally well in comparison 
to other, previously-reported megaprimer-based cloning methods. However, what about 
more popular cloning methods such Gibson Assembly cloning (Gibson, 2011; Tyo et 
al., 2009) or Ligation Independent Cloning (LIC) (Zhang et al., 2002)? Both of these 
methods are often advertised as being able to achieve full cloning in less than an hour 
and less than 3 hours, respectively, appearing to be much faster when compared to 6 
hour duration time provided for QuickStep-Cloning. Surprisingly, these general 
estimates usually not only neglect the time needed for bacterial transformation but also 
assume that two DNA fragments to be joined already contain complementary terminal 
regions and that recipient plasmid is already linearized. The last point is particularly 
salient  in the case of any general cloning experiment utilizing Gibson Assembly or LIC, 
as recipient plasmid has to be linearized, most often than not, with either restriction 
enzymes or inverse PCR. Use of restriction enzymes for this purpose introduces a host of 
problems inherent to the traditional, restriction-ligation-based cloning protocol, such as 
dependency on the availability of unique restriction sites in a cloning vector. Application 
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of inverse PCR allows for sequence-independent cloning, however, it provides some of 
the drawbacks associated with megaprimer-based cloning (e.g., reliance on error-prone 
polymerase of choice and necessity of careful primer design). If Gibson assembly was to 
be used together with inverse PCR to clone 1 kb DNA fragment into 7 kb expression 
vector (analogous to the proof-of-concept egfp cloning experiment presented in here), 
according to our conservative estimates, about 3 hours would be needed to perform the 
inverse PCR and subsequent DpnI digestion (to remove any traces of parental vector) 
and plasmid purification. Adding to this the time needed to perform enzymatic assembly 
and bacterial transformation, the total time of performing cloning via Gibson Assembly 
appears to be comparable to QuickStep-Cloning. Worthy of note, recipient plasmid 
linearization and amplification of DNA insert combined with introduction of 
complementary overhangs require design of the same number of primers as QuickStep-
Cloning. Taking into account the cost of enzymatic reaction components (T5 
exonuclease, Taq ligase, suitable polymerase and appropriate buffer sustaining 
simultaneous activity of all three enzymes) and the need of synthesizing four different 
primers, Gibson Assembly cloning seems to be more costly and resource-intensive than 
QuickStep-Cloning. What is more, use of highly-competent bacterial strains for Gibson 
Assembly is highly recommended. Without shadow of a doubt, Gibson Assembly 
remains a powerful and highly versatile molecular-biology tool, which involves a broad 
range of applications including, but not limited to, multiple-fragment assembly and 
molecular cloning coupled to simultaneous deletion of a DNA fragment. The same 
argument applies equally well to Ligation Independent Cloning. In our opinion, 
however, for certain applications such as point insertion of long DNA stretches into a 
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cloning vector, QuickStep-Cloning provides an attractive alternative to even the most 
popular and established cloning methods.   
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2.4 Conclusions 
Based on the presented experimental results, it can be claimed that QuickStep-Cloning 
is a rapid and highly efficient method of molecular cloning. A DNA fragment of interest 
can be inserted into any position on the recipient vector and fully cloned in less than 6 
hours, without the need of DNA ligation and with only one simple PCR purification 
step. The usefulness of QuickStep-Cloning is certainly not limited to standard cloning 
experiments, involving transfer of a gene sequence from a donor vector to a recipient 
plasmid. The developed method could be especially useful for protein tagging or, 
potentially, cloning DNA fragments directly from genomic DNA. The method should 
also facilitate the vital process of constructing and testing new biological circuits by 
allowing faster integration of genetic elements. We envisage that QuickStep-Cloning 
would find its applications in the developing fields of protein engineering, metabolic 
engineering and synthetic biology.  
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2.5 Methods 
2.5.1 Materials 
All enzymes, deoxyribonucleotides and DNA ladders were purchased from New 
England Biolabs (Ipswich, USA). 
2.5.2 Primers 
Primers used in this study were synthesized by Eurofins Genomics (Ebersberg, 
Germany). Melting temperatures of oligonucleotides were determined using the New 
England Biolabs Tm Calculator (https://www.neb.com/tools-and-resources/interactive-
tools/tm-calculator). Four primers were used in egfp cloning experiment: EGFP-Fwd (5’- 
ATGGTGAGCAAGGGCGAG-3’, 18 bp), IntA-EGFP-Fwd (5’- CGAAAACCTGTAC 
TTCCAGGGTGGATCCATGGTGAGCAAGGGCGAG-3’, 46 bp), EGFP-Rev (5’-
TTACTTGTACAGCTCGTCCATG-3’, 22 bp) and IntB-EGFP-Rev (5’- CTAGGAT 
CTGACTGCGGCTCCTCCATTTACTTGTACAGCTCGTCCATG-3’, 48 bp). 
Underlined parts of IntA-Fwd and IntB-Rev are identical to Fwd and Rev primers, 
respectively, and the remaining parts correspond to the two megaprimer annealing sites 
flanking DNA insertion point present in pET24a-HLTEV-p53. Similarly, the following 
four primers were used for rfp cloning experiment: RFP-Fwd (5’-
ATGGCGAGTAGCGAAGACG-3’, 19 bp), IntA-RFP-Fwd (5’-CGAAAACCTGTAC 
TTCCAGGGTGGATCCATGGCGAGTAGCGAAGACG-3’, 47 bp), RFP-Rev (5’-
TTAAGCACCGGTGGAGTGACG-3’, 21 bp) and IntB-RFP-Rev (5’- CTAGGATCT 
GACTGCGGCTCCTCCATTTAAGCACCGGTGGAGTGACG-3’, 47 bp). 
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2.5.3 QuickStep-Cloning 
To transfer egfp gene from pEGFP (Clontech Laboratories, Mountain View, USA) into 
pET24a-HLTEV-p53 plasmid, two asymmetric PCRs were carried out in parallel. 
Asymmetric PCR mixture I (50 µl) contained 1× Q5 Reaction Buffer, 200 µM of each 
dNTP, 500 nM EGFP-Fwd primer, 10 nM IntB-EGFP-Rev primer, 0.2 ng pEFGP, and 
1 U Q5 High-Fidelity DNA Polymerase. Asymmetric PCR mixture II (50 µl) contained 
1× Q5 Reaction Buffer, 200 µM of each dNTP, 10 nM IntA-EGFP-Fwd primer, 500 
nM EGFP-Rev primer, 0.2 ng pEFGP and 1 U Q5 High-Fidelity DNA Polymerase. 
Both mixtures were thermocycled using the following conditions: (i) 30 s initial 
denaturation at 98°C and (ii) 30 cycles of 7 s denaturation at 98°C, 20 s annealing at 
65°C and 30 s extension at 72°C. The two PCR products were purified using QIAquick 
PCR Purification Kit (Qiagen, Hilden, Germany) and their DNA concentration was 
determined using NanoDrop 2000 (Thermo Scientific, Wilmington, USA). For 
megaprimer PCR, the mixture (50 µl) contained 1× Q5 Reaction Buffer, 200 µM of 
each dNTP, 200 ng of purified asymmetric PCR product I, 200 ng of purified 
asymmetric PCR product II, 20 ng pET24a-HLTEV-p53 and 1 U Q5 High-Fidelity 
DNA Polymerase. The mixture was thermocycled according to the following program: 
(i) 30 s initial denaturation at 98°C, (ii) 25 cycles of 10 s denaturation at 98°C, 4 min 
annealing and extension at 72°C, and (iii) 2 min final extension at 72°C. Forty units of 
DpnI were subsequently added to the PCR mixture and incubated at 37ºC for 15 min 
to remove the parental pET24a-HLTEV-p53 plasmids. To clone rfp gene from 
pBbA8k-RFP,  purchased from Addgene (plasmid #35273), into pET24a-HLTEV-p53 
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plasmid, the same protocol was followed, using a dedicated primer set (RFP-Fwd, IntA-
RFP-Fwd, RFP-Rev and IntB-RFP-Rev) and corresponding annealing temperature of 
68°C (provided by New England Biolabs Tm Calculator) for the two asymmetric PCRs. 
2.5.4 Restriction-free (RF) cloning 
PCR mixture (50 µl) containing 1× Q5 Reaction Buffer, 200 µM of each dNTP, 500 
nM IntA-Fwd primer, 500 nM IntB-Rev primer, 0.2 ng pEFGP, and 1 U Q5 High-
Fidelity DNA Polymerase was thermocycled using the same program as asymmetric 
PCR in QuickStep-Cloning: (i) 30 s initial denaturation at 98°C and (ii) 30 cycles of 7 s 
denaturation at 98°C, 20 s annealing at 65°C and 30 s extension at 72°C. The PCR 
product was purified using QIAquick PCR Purification Kit and its DNA concentrations 
was determined using NanoDrop 2000. Megaprimer PCR mixture (50 µl) containing 
1× Q5 Reaction Buffer, 200 nM of each dNTP, 400 ng purified PCR product, 20 ng 
pET24a-HLTEV-p53 and 1 U Q5 High-Fidelity DNA Polymerase was thermocycled 
in the same conditions as QuickStep-Cloning megaprimer PCR: (i) 30 s initial 
denaturation at 98°C, (ii) 25 cycles of 10 s denaturation at 98°C, 4 min annealing and 
extension at 72°C, and (iii) 2 min final extension at 72°C. Forty units of DpnI were 
added to the PCR mixture and incubated at 37ºC for 15 min to remove the parental 
pET24a-HLTEV-p53 plasmids. To clone rfp gene from pBbA8k-RFP into pET24a-
HLTEV-p53 plasmid, the same protocol was followed, using a dedicated primer set 
(RFP-Fwd, IntA-RFP-Fwd, RFP-Rev and IntB-RFP-Rev) and corresponding annealing 
temperature of 68°C for the first PCR. 
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2.3.5 DNA gel electrophoresis 
PCR  products were analyzed using either 0.7% or 1.5% agarose gel. DNA was stained 
using Diamond Nucleic Acid Dye (Promega, Madison, USA). DNA ladders used were 
Quick-Load 1 kb DNA Ladder and Quick-Load 100 bp DNA Ladder. 
2.5.6 Transformation and clone analysis 
E. coli DH5α and C41 (DE3) were transformed with 5 µl of DpnI-digested products of 
QuickStep-Cloning or RF cloning, using a standard chemical transformation protocol 
(Minagawa et al., 2007). Concurrently, the two bacterial strains were transformed with 
1 µl of 1 ng/µl intact pET24a-HLTEV-p53 to estimate transformation efficiency. 
Transformed bacteria were plated on TYE agar plates (10 g/l tryptone, 5 g/l yeast 
extract, 8 g/l sodium chloride and 15 g/l agar) supplemented with: (i) 100 µg/ml 
ampicillin, (ii) 50 µg/ml kanamycin, and (iii) 50 µg/ml kanamycin and 1 mM IPTG. 
The plates were incubated overnight at 37°C and for further 12 h at 30°C. The number 
of EGFP-expressing colonies was determined by visual inspection using UV 
transilluminator. Five EGFP-negative colonies, together with one EGFP-expressing 
colony and one colony containing original pET24a-HLTEV-p53 were used to inoculate 
separate 5 ml aliquots of TB-based auto-induction media (12 g/l tryptone, 24 g/l yeast 
extract, 3.3 g/l (NH4)2SO4, 6.8 g/l KH2PO4, 7.1 g/l Na2HPO4, 0.5 g/l glucose, 2.1 g/l 
α-Lactose monohydrate and 0.31 g/l MgSO4·7H2O). After 24 h incubation at 30°C, 3 
ml aliquots of cell culture were spun down in 1.5 ml microcentrifuge tubes and the 
resultant cell pellets were visually inspected for EGFP expression. Ten EGFP-expressing 
colonies and five EGFP-negative colonies obtained using QuickStep-Cloning, and five 
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EGFP-expressing colonies and five EGFP-negative colonies obtained using RF cloning 
[picked randomly from C41 (DE3) Kan+IPTG plate] were grown overnight at 37°C in 
5 ml 2×TY media (16 g/l tryptone, 10 g/l yeast extract and 5 g/l NaCl). The 
recombinant plasmids were purified using QIAprep Spin Miniprep Kit (Qiagen) and 
sequenced by Source BioScience (Nottingham, UK). The same transformation protocol 
was used for rfp cloning experiment. The number of RFP-expressing colonies was 
determined by visual inspection. Three RFP-expressing colonies were used to inoculate: 
(i) 5 ml 2×TY media, (ii) 5 ml 2×TY media supplemented with 1 mM IPTG, and (iii) 
5 ml 2×TY media supplemented with 0.1% w/v arabinose. After 48 h incubation at 
30°C, 3 ml aliquots of cell culture were spun down in 1.5 ml microcentrifuge tubes and 
the resultant cell pellets were visually inspected for RFP expression. Plasmids from five 
RFP-expressing colonies and five RFP-negative colonies obtained using QuickStep-
Cloning were isolated and sent for sequencing. 
2.5.7 Estimated cloning times reported in Table 2.3 – calculations 
Cloning times have been determined for the experiment involving insertion of 1 kb 
DNA fragment into 7 kb recipient plasmid. Time needed to prepare necessary PCR 
mixtures has not been included in the calculations (as it is very difficult to be accurately 
estimated). Exact times of particular steps involved in the PCR and recommended time 
of DpnI digestion and enzymatic phosphorylation-ligation have been sourced from 
references provided in Table 2.3. As a large fraction of PCR duration involves changing 
the temperature of reaction mixtures, additional 45 s has been added to each cycle to 
account for this fact – e.g., estimated time of one cycle involving 7 s denaturation, 20 s 
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annealing and 30 s extension is 102 s (57 s of incubation + 45 s needed for 
thermocycling).  
1. QuickStep-Cloning 
1st PCR:  - 30 cycles: 7 s denaturation, 20 s annealing, 30 s/kb 
extension 
    - Final extension: - 
    Total PCR duration time for 1 kb insert: 1 h 
Purification:   Column-based PCR purification 
    Estimated time: 30 min 
2nd PCR:  - 25 cycles; 10 s denaturation, 20 s annealing, 30 s/kb 
extension 
    - final extension: 2 min 
Total PCR duration time for 7 kb recipient plasmid: 2 h 
DpnI digestion   15 min 
Phosphorylation-ligation None 
Transformation  1 h 30 min 
Total time   5 h 15 min 
 
2. RF cloning 
1st PCR:  - 20 cycles: 7 s denaturation, 20 s annealing, 30 s/kb 
extension 
    - Final extension: - 
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    Total PCR duration time for 1 kb insert: 40 min 
Purification:   Column-based PCR purification 
    Estimated time: 30 min 
2nd PCR:  - 35 cycles; 30 s denaturation, 60 s annealing, 120 s/kb 
extension 
    - Final extension: - 
Total PCR duration time for 7 kb recipient plasmid: 
9 h 30 min 
DpnI digestion   2 h 
Phosphorylation-ligation None 
Transformation  1 h 30 min 
Total time   14 h 
 
3. ABI-REC 
1st PCR:  - 30 cycles: 15 s denaturation, 30 s annealing, 60 s/kb 
extension 
    - Final extension: 2 min 
Total time for 1 kb insert and 7 kb recipient plasmid: 
4 h 15 min 
Purification:   None 
2nd PCR:    None 
DpnI digestion   2 h 
Phosphorylation-ligation None 
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Transformation  1 h 30 min 
Total time   7 h 45 min 
 
4. RAM cloning 
1st PCR:  - 20 cycles: 35 s denaturation, 35 s annealing, 30 s/kb 
extension 
    - Final extension: 5 min 
    Total PCR duration time for 1 kb insert: 1 h 
Purification:   Gel extraction 
    Estimated time: 1h 30 min 
2nd PCR:  - 15 cycles; 35 s denaturation, 35 s annealing, 30 s/kb 
extension 
    - Final extension: 5 min 
Total PCR duration time for 7 kb recipient plasmid: 
1 h 30 min 
DpnI digestion   2 h 20 min 
Phosphorylation-ligation None 
Transformation  1 h 30 min 
Total time   7 h 45 min 
5. EMP cloning 
1st PCR:  - 25 cycles: 10 s denaturation, 30 s annealing, 15 s/kb 
extension 
    - Final extension: - 
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    Total PCR duration time for 1 kb insert: 45 min 
Purification:   Column-based PCR purification 
    Estimated time: 30 min 
2nd PCR:  - 25 cycles; 10 s denaturation, 30 s annealing, 30 s/kb 
extension 
    - Final extension: 2 min 
Total PCR duration time for 7 kb recipient plasmid: 2 h 
DpnI digestion   30 min 
Phosphorylation-ligation 2 h 
Transformation  1 h 30 min 
Total time   7 h 15 min 
 
5. IFPC 
1st PCR:  - 25 cycles: 15 s denaturation, 20 s annealing, 30 s/kb 
extension 
    - Final extension: 7 min 
    Total PCR duration time for 1 kb insert: 1 h 
Purification:   Gel extraction 
    Estimated time: 1h 30 min 
2nd PCR:  - 25 cycles; 20 s denaturation, 30 s annealing, 30 s/kb 
extension 
    - Final extension: 7 min 
Total PCR duration time for 7 kb recipient plasmid: 2 h 
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DpnI digestion   None 
Phosphorylation-ligation 30 min 
Transformation  1 h 30 min 
Total time   6 h 30 min 
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Chapter 3 
 
QuickStepS-Cloning 
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3.1 Brief introduction 
QuickStep-Cloning presented in Chapter 2 builds upon the previously-reported 
methods to expedite the process of molecular cloning. After QuickStep-Cloning was 
developed, it was identified that, in practice, the first part of the method, involving the 
synthesis of megaprimer primer with 3’ overhangs, constitutes a significant bottleneck 
for the whole process of gene cloning. This is caused by the requirement of performing 
two parallel asymmetric PCRs to obtain the desired DNA fragments.  
As a result, it is predicted that QuickStep-Cloning could be significantly improved, if 
the synthesis of the primer was achieved in an easier and simpler way. 
 
Figure 3.1  Chemical structure of (A) DNA, containing standard phosphodiester 
bond between two neighbouring nucleosides, and (B) DNA containing 
phosphorothioate bond. The difference in chemical structure is clearly 
marked in red   
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Use of phosphorothioate oligonucleotides could potentially provide such opportunity. 
Replacement of a usual phosphodiester internucleotide  linkage with a phosphorothioate 
bond (Figure 3.1), constitutes one of the most common type of oligonucleotide 
modification, used most frequently to make a given oligonucleotide resistant to the 
action of nucleases. However, phosphorothioate bonds have got another interesting 
characteristic – they are susceptible to iodine cleavage in alkaline solutions (Gish and 
Eckstein, 1988). This property has been utilised in the development of several molecular 
tools, including mutagenesis (Dennig et al., 2011; Wong et al., 2004b) and gene cloning 
(Blanusa et al., 2010).  
 
Figure 3.2  Comparison of the megaprimer synthesis stage between (A) original 
QuickStep-Cloning and (B) improved version of the method, utilising 
phosphorothioate oligonucleotides, where (1) denotes a standard PCR 
with phosphorothioate oligonucleotides and (2) represents 5 min 
incubation at 70°C in 10 mM iodine.  
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The incorporation of phosphorothioate oligonucleotides into QuickStep-Cloning 
should significantly streamline the whole procedure (Figure 3.2). In the new version of 
the method, called QuickStepS-Cloning, the two asymmetric PCRs are replaced with a 
single PCR and subsequent 5 min incubation of the PCR product in 10 mM iodine and 
10% ethanol, at 70°C – as described in (Blanusa et al., 2010). 
 It should be also noted that, in QuickStep-Cloning, the two asymmetric PCRs produce 
not only the desired product but also a certain fraction of megaprimer pairs that are 
completely complementary (identically, to the megaprimer design for RF cloning). This 
fraction of unwanted side-products should be much lower when the strategy involving 
phosphorothioate oligonucleotides is utilised. As a result, it is envisaged that the new 
method design will not only expedite and simplify the whole process but it will also 
increase the overall cloning efficiency. 
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3.2 Results and Discussion 
3.2.1 Optimisation 
QuickStepS-Cloning was optimised based on rfp cloning experiment, described in 
Chapter 2, where rfp gene from Kanr-pBbA8k-RFP (Figure 2.10) is cloned into Kanr-
pET24a-HLTEV-p53. 
After the first PCR with phosphorothioate oligonucleotides, 6.25 µl of 0.5 M Tris-HCl 
buffer (pH 9) and 6.25 µl 100 mM iodine in absolute ethanol were added to 50 µl of 
the PCR product. After mixing, the resultant mixture was incubated for 5 min at 70°C 
and then snap cooled on ice to prevent the cleaved DNA fragments from properly re-
annealing to the uncovered 3’ overhangs. After a quick PCR purification (using a silica-
based spin column), the megaprimer PCR was conducted as described in Chapter 2.    
During the method optimisation, the influence of different parameters on the yield of 
QuickStepS-Cloning was investigated (Figure 3.3). Firstly, it was shown that there is no 
discernible difference between 5 minutes and 2 h incubation with iodine, showing that 
5 min incubation is sufficient for cleavage of phosphorothioate  bonds to go to 
completion (Figure 3.3A). It was also investigated whether there is a need for an 
additional purification after the first PCR, however, it was shown that the addition of 
the extra step only barely slightly the final yield (Figure 3.3B). 
Finally, similarly to Chapter 2, the influence of megaprimer concentration, number of 
PCR cycles and vector concentration was thoroughly examined (Figure 3.3C-E). It is 
worth noting that in the case of 35 cycles, the increased amount of the product, visible 
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on the agarose gel, did not translate into higher cloning efficiency. This was most likely 
caused by a high amount of side-products that interfered with the subsequent chemical 
transformation. 
 
Figure 3.3  Optimisation of QuickStepS-Cloning. Yield of megaprimer PCR: (A) 
for different durations of incubation with iodine, (B) with and without 
additional purification stage before the incubation with iodine,  (C) for 
different concentrations of megaprimer (D) different number of cycles of 
megaprimer PCR and (E) vector concentration. The band at 8 kb 
represents the product, whereas the band at 6 kb shows the template 
plasmid.  
D E
A B C
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3.2.2 Method comparison 
The optimised protocol was compared with RF cloning and the previous version of the 
method (Table 3.1 and Figure.3.4). 
Table 3.1  Comparison of QuickStepS-Cloning, using 25 or 30 cycles of 
megaprimer PCR, with RF cloning and QuickStep-Cloning, as 
determined by rfp cloning experiment. Colony counts for E. coli 
C41 (DE3) transformed with the products of aforementioned cloning 
methods and plated on agar plates supplemented with: 50 µg/ml 
kanamycin and 1 mM IPTG. Transformation efficiency was determined 
based on concurrent transformation of 1 ng intact pET24a-HLTEV-p53 
plasmid. Numbers in the brackets denote RFP-expressing colonies, as 
determined by visual inspection of the plates. 
QuickStep-
Cloning 
RF Cloning QuickStepS-
Cloning (25c ) 
QuickStepS-
Cloning (30 c) 
Transformation 
efficiency [cfu/µg] 
9(9) 0 19(16) 43(41) 2·104 
 
The presented results clearly show that QuickStepS-Cloning exhibits superior 
performance in comparison to the other two method, resulting in 2-4 fold  
improvement (depending on the number of cycles used for megaprimer PCR) in cloning  
efficiency in comparison to QuickStep-Cloning. At the same time, the percentage of 
RFP-positive colonies remains exceptionally high. Surprisingly, RF cloning did not 
produce any clones. This was likely caused by a low transformation efficiency achieved 
during this experiment. A higher transformation efficiency would probably be needed to 
observe any colonies produced by RF cloning. 
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Figure 3.4  Yield of RF cloning, QuickStep-Cloning and QuickStepS-Cloning (25 
cycles of megaprimer PCR), as determined for rfp cloning experiment. 
3.2.3 Method validation 
To prove that the developed protocol is applicable to other cloning experiments, 
without the need of further optimisation, QuickStepS-Cloning was used to clone 
P450 BM3 reductase gene from pCWori-BM3 plasmid into pETM11-BM3 WT 
plasmid (Figure 3.5). This cloning can be classified as relatively challenging due to high 
lengths of both the cloned gene and the recipient plasmid – 2 and 7 kb respectively 
(usually, the overall number of transformants provided by a cloning process significantly 
decreases when longer DNA fragments are being combined). To act as a comparison, 
RF cloning was performed in parallel.   
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Figure 3.5  Outline of P450 BM3 reductase gene cloning experiment. 
Owing to high length of the cloned gene and the recipient plasmid, the amount of 
resultant DNA was much lower (Figure 3.6) in comparison to the rfp cloning 
experiment (Figure 3.4). 
 
Figure 3.6  Yield of RF cloning and QuickStepS-Cloning, as determined for P450 
BM3 reductase gene cloning experiment. 
Despite the low amount of recombinant DNA produced, as determined by the gel 
electrophoresis, a significant number colonies were obtained when E. coli was 
transformed with the product of QuickStepS-Cloning. Five of the 49 available colonies 
pCWori-BM3
P450 BM3 
reductase gene
(~2 kb)
Point insertion
pETM11-BM3 WT
(~7 kb)
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were picked at random and the presence of the insert was confirmed in all 5 of them via 
a colony PCR. Again, RF cloning did not produce any colonies, which this time was 
caused by both the insufficient transformation efficiency and the complexity of the 
molecular cloning involved. Consequently, it was shown that the developed method 
performs much better than the state-of-the-art method. 
Table 3.2  Results of P450 BM3 reductase gene cloning experiment. Colony counts 
for E. coli strains DH5α transformed with the products of RF cloning 
and of QuickStep-Cloning and plated on agar plates supplemented with 
50 µg/ml kanamycin. Transformation efficiency was determined based 
on concurrent transformation of 1 ng intact pETM11-BM3 WT 
plasmid. 
QuickStepS-Cloning RF Cloning 
Transformation 
efficiency [cfu/µg] 
49 0 4·104 
 
3.2.4 Application to directed evolution 
To make use of the exceptionally high cloning efficiency of QuickStepS-Cloning, the 
applicability of the method to protein engineering was investigated. 
Firstly, rfp  cloning experiment was performed once again using QuickStepS-Cloning, 
however, this time, the mutagenic were incorporated into the first PCR – rfp gene was 
amplified using Taq polymerase (NEB) in the presence of imbalanced concentration of 
dNTPs and high MnCl2 concentration. 
In parallel, MEGAWHOP was used to perform similar mutagenesis and, subsequently, 
integrate the resultant gene library into the plasmid. It should be noted that 
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MEGAWHOP differs slightly from RF cloning and MEGAWHOP cloning, discussed 
in Chapter 2. In the MEGAWHOP protocol the recipient plasmid is replaced with a 
vector that already contains the gene to be mutagenised (Miyazaki and Takenouchi, 
2002). As such, normal cloning needs to be performed in advance in order to utilise the 
method. The trade-off is significantly higher number of transformants produced by the 
method, due to a much better annealing of the megaprimer (the annealing is no longer 
limited to the terminal regions of the megaprimer). As a result, MEGAWHOP is a 
popular method of choice for many directed evolution experiments where a large library 
is needed.  
E. coli C41 (DE3) was transformed with a purified product of both QuickStepS-
Cloning and MEGAWHOP via electroporation. The results of the experiment are 
presented in Table 3.3. As shown, the QuickStep-Cloning produces a combinatorial 
library of a similar size to MEGAWHOP, without the need of performing prior cloning 
(utilising a plasmid without the target gene as a template) 
Table 3.3  Comparison of the library size when performing an experiment involving 
rfp mutagenesis via QuickStepS-Cloning and MEGAWHOP. Colony 
counts for E. coli C41 (DE3) transformed with the products of 
QuickStepS-Cloning and MEGAWHOP via electroporation and plated 
on agar plates supplemented with 50 µg/ml kanamycin and 1 mM 
IPTG. Transformation efficiency was determined based on concurrent 
transformation of 1 pg intact pET24a-HLTEV-p53 plasmid. 
QuickStepS-Cloning MEGAWHOP 
Transformation 
efficiency [cfu/µg] 
1.0·104 1.5·104 2·106 
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To further demonstrate the usefulness of QuickStepS-Cloning to directed evolution, 
three protein variants exhibiting a different colour under visible light were isolated 
during the described experiment (Figure 3.7). The difference in colour was further 
confirmed by absorbance measurements (Figure 3.8). The genes encoding for the three 
proteins were sequenced and associated mutations were identified .(M1: T195S; M2: 
F91L, M3:Q66L and T202A). 
 
 
Figure 3.7  Comparison of the wild-type RFP and three isolated mutants: (A) cell 
pellets from the expressing E. coli C41 (DE3), (B) purified protein 
(purification achieved with Ni-NTA Spin Columns; Qiagen), and (C) 
purified protein under UV light. (-ve) denotes negative control: E. coli 
C41 (DE3) without a plasmid in (A) and PB buffer in (B) and (C). 
WT M1 M2 M3 -ve
A
B
C
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Figure 3.8  Absorbance spectra of the wild-type RFP and three isolated mutants. 
Proteins were purified using Ni-NTA Spin Columns; (Qiagen). 
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3.3 Conclusion 
QuickStepS-Cloning utilises phosphorothioate oligonucleotides to improve the cloning 
method presented in Chapter 2. By targeting the identified bottleneck of megaprimer 
synthesis, the new protocol not only expedites and simplifies the whole procedure of 
gene cloning but also achieves significantly higher cloning efficiency. It is demonstrated 
that QuickStepS-Cloning cloning can compete with even the most efficient methods of 
incorporating combinatorial libraries such as MEGAWHOP. Finally, the usefulness of 
the method to protein engineering is clearly demonstrated by incorporating random 
mutagenesis into method and performing a proof-of-concept directed evolution 
experiment. The same approach can also be used for fine tuning gene expression by 
quickly incorporating a library of mutagenised promoters into a biological circuit.  
All in all, QuickStepS-Cloning should be of great interest to synthetic biology because 
not only it facilitates the construction of biological circuits (expanding the capabilities 
and the throughput of the previous method) but also, when used in combination with 
directed evolution, it can expedite the process of acquiring new, well-defined biological 
parts.  
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3.4 Methods 
3.4.1 Materials 
All enzymes, deoxyribonucleotides and DNA ladders were purchased from New 
England Biolabs (Ipswich, USA). 
3.4.2 Primers 
Primers used in this study were synthesized by Eurofins Genomics (Ebersberg, 
Germany). Melting temperatures of oligonucleotides were determined using the New 
England Biolabs Tm Calculator (https://www.neb.com/tools-and-resources/interactive-
tools/tm-calculator). Six primers, in total, depending on the method of choice were used 
for rfp cloning experiment. RFP-Fwd (5’-ATGGCGAGTAGCGAAGACG-3’, 19 bp), 
IntA-RFP-Fwd (5’-CGAAAACCTGTACTTCCAGGGTGGATCCATGGCGAGTAG 
CGAAGACG-3’, 47 bp), RFP-Rev (5’-TTAAGCACCGGTGGAGTGACG-3’, 21 bp), 
IntB-RFP-Rev (5’- CTAGGATCTGACTGCGGCTCCTCCATTTAAGCACCGGTG 
GAGTGACG-3’, 47 bp), IntA-RFP-Fwd-P (5’- CGAAAACCTGTACTtCCAGGGTG 
GATCCaTGGCGAGTAGCGAAGACG-3’, 47 bp) and IntB-RFP-Rev-P (5’- CTAGG 
ATCTGACTgCGGCTCCTCCATtTAAGCACCGGTGGAGTGACG-3’, 47 bp). 
The small letters in the DNA sequence signify the location of the phosphorothioate 
bonds. 
Underlined parts of IntA-Fwd and IntB-Rev are identical to Fwd and Rev primers, 
respectively, and the remaining parts correspond to the two megaprimer annealing sites 
flanking DNA insertion point present in pET24a-HLTEV-p53.  
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The following two primers were used for P450 BM3 reductase gene cloning experiment: 
P450_IntB_Rev (5’- GTCGACGGAGcTCGAATTCTTaCCCAGCCCACACGTCT 
TTTGC -3’, 43 bp) and P450_IntA_Fwd (5’- GGTAAAAGCAAAATcGAAAAAAATT 
CCGCTtGGCGGTATTCCTTCACCTAGCACTG -3’, 56 bp). The small letters in 
the DNA sequence signify the location of the phosphorothioate bonds.  
3.4.3 QuickStep-Cloning 
To clone rfp gene from pBbA8k-RFP into pET24a-HLTEV-p53 plasmid, two 
asymmetric PCRs were carried out in parallel. Asymmetric PCR mixture I (50 µl) 
contained 1× Q5 Reaction Buffer, 200 µM of each dNTP, 500 nM RFP-Fwd primer, 
10 nM IntB-RFP-Rev primer, 0.2 ng pBbA8k-RFP, and 1 U Q5 High-Fidelity DNA 
Polymerase. Asymmetric PCR mixture II (50 µl) contained 1× Q5 Reaction Buffer, 200 
µM of each dNTP, 10 nM IntA-RFP-Fwd primer, 500 nM RFP-Rev primer, 0.2 ng 
pRGP and 1 U Q5 High-Fidelity DNA Polymerase. Both mixtures were thermocycled 
using the following conditions: (i) 30 s initial denaturation at 98°C and (ii) 30 cycles of 
7 s denaturation at 98°C, 20 s annealing at 68°C and 30 s extension at 72°C. The two 
PCR products were purified using QIAquick PCR Purification Kit (Qiagen, Hilden, 
Germany) and their DNA concentration was determined using VersaWave (Expedeon). 
For megaprimer PCR, the mixture (50 µl) contained 1× Q5 Reaction Buffer, 200 µM of 
each dNTP, 200 ng of purified asymmetric PCR product I, 200 ng of purified 
asymmetric PCR product II, 20 ng pET24a-HLTEV-p53 and 1 U Q5 High-Fidelity 
DNA Polymerase. The mixture was thermocycled according to the following program: 
(i) 30 s initial denaturation at 98°C, (ii) 25 cycles of 10 s denaturation at 98°C, 4 min 
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annealing and extension at 72°C, and (iii) 2 min final extension at 72°C. Forty units of 
DpnI were subsequently added to the PCR mixture and incubated at 37ºC for 15 min 
to remove the parental pET24a-HLTEV-p53 plasmids.  
3.4.4 Restriction-free (RF) cloning 
PCR mixture (50 µl) containing 1× Q5 Reaction Buffer, 200 µM of each dNTP, 500 
nM IntA-RFP-Fwd primer, 500 nM IntB-RFP-Rev primer, 0.2 ng pBbA8k-RFP, and 1 
U Q5 High-Fidelity DNA Polymerase was thermocycled using the same program as 
asymmetric PCR in QuickStep-Cloning: (i) 30 s initial denaturation at 98°C and (ii) 30 
cycles of 7 s denaturation at 98°C, 20 s annealing at 68°C and 30 s extension at 72°C. 
The PCR product was purified using QIAquick PCR Purification Kit and its DNA 
concentrations was determined using VersaWave (Expedeon). Megaprimer PCR 
mixture (50 µl) containing 1× Q5 Reaction Buffer, 200 nM of each dNTP, 400 ng 
purified PCR product, 20 ng pET24a-HLTEV-p53 and 1 U Q5 High-Fidelity DNA 
Polymerase was thermocycled with the following conditions: (i) 30 s initial denaturation 
at 98°C, (ii) 25 cycles of 10 s denaturation at 98°C, 4 min annealing and extension at 
72°C, and (iii) 2 min final extension at 72°C. Forty units of DpnI were added to the 
PCR mixture and incubated at 37ºC for 15 min to remove the parental pET24a-
HLTEV-p53 plasmids. 
To clone P450 BM3 reductase gene from pCWori-BM3 into pETM11-BM3 WT 
plasmid, the same protocol was followed, using a dedicated primer set (P450_IntA_Fwd 
and P450_IntB_Rev) and, for the first PCR, the following thermocycling conditions 
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were used: (i) 30 s initial denaturation at 98°C and (ii) 30 cycles of 7 s denaturation at 
98°C, 80 s annealing and extension at 72°C. 
3.4.5 QuickStepS-Cloning 
PCR mixture (50 µl) containing 1× Q5 Reaction Buffer, 200 µM of each dNTP, 500 
nM IntA-RFP-Fwd-P primer, 500 nM IntB-RFP-Rev-P primer, 0.2 ng pBbA8k-RFP, 
and 1 U Q5 High-Fidelity DNA Polymerase was thermocycled using the same program 
as asymmetric PCR in QuickStep-Cloning: (i) 30 s initial denaturation at 98°C and (ii) 
30 cycles of 7 s denaturation at 98°C, 20 s annealing at 68°C and 30 s extension at 
72°C.  
6.25 µl of 0.5 M Tris-HCl buffer (pH 9) and 6.25 µl iodine in absolute ethanol were 
added to 50 µl of the PCR product. After brief mixing by pipetting, the resultant 
mixture was incubated for 5 min at 70°C and then snap cooled on ice. 
Subsequently, it was purified using QIAquick PCR Purification Kit and its DNA 
concentrations was determined using VersaWave (Expedeon). Megaprimer PCR 
mixture (50 µl) containing 1× Q5 Reaction Buffer, 200 nM of each dNTP, 400 ng 
purified PCR product, 20 ng pET24a-HLTEV-p53 and 1 U Q5 High-Fidelity DNA 
Polymerase was thermocycled in the same conditions as QuickStep-Cloning megaprimer 
PCR: (i) 30 s initial denaturation at 98°C, (ii) 25 cycles of 10 s denaturation at 98°C, 4 
min annealing and extension at 72°C, and (iii) 2 min final extension at 72°C. Forty 
units of DpnI were added to the PCR mixture and incubated at 37ºC for 15 min to 
remove the parental pET24a-HLTEV-p53 plasmids. 
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To clone P450 BM3 reductase gene from pCWori-BM3 into pETM11-BM3 WT 
plasmid, the same protocol was followed, using a dedicated primer set (P450_IntA_Fwd 
and P450_IntB_Rev) and, for the first PCR, the following thermocycling conditions 
were used: (i) 30 s initial denaturation at 98°C and (ii) 30 cycles of 7 s denaturation at 
98°C, 80 s annealing and extension at 72°C. 
3.4.6 DNA gel electrophoresis 
PCR  products were analyzed using either 0.7% agarose gel. For visualisation purposes, 
ethidium bromide was added to the gel. Quick-Load 1 kb DNA Ladder was used as a 
DNA ladder. 
3.4.7 Chemical transformation and clone analysis 
E. coli DH5α and C41 (DE3) were transformed with 5 µl of DpnI-digested products of 
QuickStep-Cloning, QuickStepS-Cloning or RF cloning, using a standard chemical 
transformation protocol (Minagawa et al., 2007). Concurrently, the bacterial strains 
were transformed with 1 µl of 1 ng/µl intact pET24a-HLTEV-p53 or pETM11-
BM3 WT to estimate transformation efficiency. Transformed bacteria were plated on 
TYE agar plates (10 g/l tryptone, 5 g/l yeast extract, 8 g/l sodium chloride and 15 g/l 
agar) supplemented with: 50 µg/ml kanamycin and 1 mM IPTG (in the case of rfp 
cloning experiment). The plates were incubated overnight at 37°C and for further 12 h 
at 30°C. The number of RFP-expressing colonies was determined by visual inspection 
using UV transilluminator.  
 
  
 
| 147 | 
3.4.8 Error-prone PCR 
PCR mixture (50 µl) containing 1× Standard Taq (Mg-free) reaction buffer, 7mM 
MgCl2, 0.05 mM MnCl2,  200 µM of dATP, 200 µM of dGTP, 1 mM of dGTP, 1 
mM of dCTP 400 nM IntA-RFP-Fwd-P or IntA-RFP-Fwd primer (depending whether 
QuickStepS-Cloning or MEGAWHOP is being used, respectively) library, 400 nM 
IntB-RFP-Rev-P or IntB-RFP-Rev primer, 50 ng pBbA8k-RFP, and 1.25 U Taq DNA 
Polymerase was thermocycled using the same program as asymmetric PCR in 
QuickStep-Cloning: (i) 30 s initial denaturation at 95°C and (ii) 30 cycles of 20 s 
denaturation at 95°C, 30 s annealing at 55°C and 45 s extension at 68°C, (iii) final 
extension at 68°C for 5 min. The PCR product was purified using QIAquick PCR 
Purification Kit and its DNA concentrations was determined using VersaWave 
(Expedeon). 
 3.4.9 MEGAWHOP  
Megaprimer PCR mixture (50 µl) containing 1× Q5 Reaction Buffer, 200 nM of each 
dNTP, 500 ng megaprimer, 50 ng pET24a-HLTEV-RFP-p53 and 1 U Q5 High-
Fidelity DNA Polymerase was thermocycled in the following conditions: (i) 30 s initial 
denaturation at 98°C, (ii) 25 cycles of 10 s denaturation at 98°C, 4 min annealing and 
extension at 72°C, and (iii) 2 min final extension at 72°C. Forty units of DpnI were 
added to the PCR mixture and incubated at 37ºC for 15 min to remove the parental 
plasmids. 
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3.4.10 Transformation of rfp library 
The product of QuicStepS-Cloning and MEGAWHOP were purified using QIAquick 
PCR Purification Kit. 1  µl of the purified mixture was used to transform E. coli DH5α 
cells using a standard protocol. After the transformation, the cell were plated at different 
dilution on LB agar plates (10 g/l tryptone, 5 g/l yeast extract, 10 g/l sodium chloride 
and 15 g/l agar) supplemented with: 50 µg/ml kanamycin and 1 mM IPTG (in the case 
of rfp cloning experiment). The plates were incubated overnight at 37°C and for further 
12 h at 30°C. Three colonies exhibiting a slightly different colour under visible light 
were identified by visual inspection and were grown overnight at 37°C in 5 ml 2×TY 
media (16 g/l tryptone, 10 g/l yeast extract and 5 g/l NaCl) supplemented with 50 
µg/ml kanamycin. 
3.4.11 Protein expression and purification 
250 µl of overnight cultures of E. coli corresponding to three isolated mutants and wild-
type RFP were used to inculcate 50 ml  LB media supplemented with kanamycin and 
grown at 37°C with shaking. When OD600 reached 0.6, the expression was induced with 
1mM IPTG. The cells were grown for further 16 h. The protein was isolated using Ni-
NTA Spin Columns (Qiagen), according to the manufacturer’s instructions. The 
absorbance measurements were conducted using UV-1600PC UV-Vis 
spectrophotometer (VWR).  
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4.1 Method outline 
As discussed in section 1.5, there exist significant limitations and lacking features in the 
area of identifying genes encoding for useful phenotypes. To provide a robust alternative 
to existing methods, a new approach to simultaneous targeting of multiple genes is being 
proposed (Figure 4.1). In this method, DNA fragments from two genomic libraries are 
integrated into a vector containing two different inducible promoters (Figure 4.2). This 
should allow for identification of interactions between distant genes and significantly 
help in evolving organisms with a desired phenotype. 
 
 
Figure 4.1   Overview of Multi-Genius: (1) genomic DNA extraction, (2) 
amplification of genomic DNA, (3) fragmentation, (4) integration of 
two genomic libraries into one plasmid containing two inducible 
promoters, and (5) selection. 
 
In the proposed method, the first step is to isolate genomic material, by extracting it 
from an organism of interest and purifying it. The isolated DNA is then amplified and 
divided into smaller fragments. Fragmentation can be achieved through a variety of 
Isolated genomic DNA
Organism exhibiting    
a desired phenotype
Amplified DNA
DNA fragments
(genomic library)
1
2
3
Genomic library 2
Insert from genomic library 1
4
Transformation
5
Expression vectorGenomic library 1
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different methods, each providing their own advantages and drawbacks. Next, the DNA 
fragments from each genomic library are cloned into the expression vector, so that each 
plasmid contains two fragments, each from a different libary. A proper cloning 
technique needs to be carefully chosen as this step is likely to constitute a primary 
bottleneck for the whole method. Resultant vectors are then transformed into a bacterial 
species that needs to be modified. Transformed cells are then incubated in selective 
conditions – for example high temperature or low pH. Plasmids can be then isolated 
from the selected cells and analysed to identify genes coding for useful phenotypes. Use 
of two inducible promoters allows for selection in [0,0], [0,1], [1,0] and [1,1] 
configurations making the gene identification much simpler. What is more, the use of 
two independent inducible promoters might prove invaluable in determining the 
optimal expression levels of a pair of identified genes. Namely, once a beneficial gene 
combination is identified, the screening can be performed in the presence of selective 
conditions and varying concentration of the two inducers (microtiter plates or gradient 
agar plates might utilised for this purpose). The optimal concentrations of the two 
inducers can be found in this way. 
 
Figure 4.2   Design of expression vector for Multi-Genius. MSC stands for multiple 
cloning site.  
MCS1
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There are several challenges that will need to be overcome to utilise the proposed 
method. Many vital and complex design decisions will need to made to ensure a proper 
operation of the method. For example, finding a suitable method for efficient 
integration of the DNA fragments from two genomic libraries into the expression vector 
will be a major challenge. Finally, a space of possible two-fragment combinations is so 
great that it will be vital to optimise the experimental protocol so that the size of library 
that can be screened with Multi-Genius is maximised. It should be also remembered 
that genomic DNA will be randomly fragmented causing some or even most of the 
them to be non-functional 
Despite the listed challenges, this project offers many potential benefits. The key aim is 
to expand upon the concept of genomic libraries and  develop a relatively simple, robust 
and cost-effective method for identifying interactions between distant genetic loci. The 
proposed method is of great scientific and industrial significance as it has a potential for 
evolving useful phenotypes in industrially-relevant bacterial strains. 
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4.2 Genomic DNA extraction 
For the purpose of genomic DNA extraction, a standard Bacterial DNA Kit from 
OMEGA Bio-Tek was used. Genomic DNA was extracted from 109 E. coli cells, 
according to manufacturer’s instructions, and its concentration and purity was analysed 
using VersaWave spectrophotometer (Table 9). The experimental results show that the 
selected kit provided DNA of sufficient concentration and quality for the proposed 
application. During the experiments, it was determined, however, that when more than 
109 cells are used (e.g., 2 ml of the overnight culture) the HiBind DNA spin-column 
becomes oversaturated and the quality of obtained DNA is very poor (data not shown). 
As a result, it is imperative to measure cell density before genomic DNA isolation to 
make sure that the recommended number of cells is not exceeded when performing the 
DNA extraction. 
Table 4.1   Concentration and purity of genomic bacterial DNA extracted from an 
overnight culture of E. coli DH5α and C41(DE3). 
Bacterial strain Final elution 
volume [µl] 
Concentration 
[ng/µl] 
260/280 ratio   
[-] 
260/230 ratio   
[-] 
E. coli DH5α 100 18.4 1.82 1.96 
E. coli C41(DE3) 100 52.5 1.89 2.16 
 
 
  
  
 
| 154 | 
4.3 DNA amplification 
The purpose of DNA amplification step is expand the applicability of Multi-Genius to 
situations when only minute amounts of genomic material are available – this might 
happen, for example, when dealing with microorganisms that are difficult to culture 
under laboratory conditions. 
 
Figure 4.3   Product of genomic DNA amplification. Genomic DNA extracted from 
DH5α (denoted as 1) and C41(DE3) (denoted as 2) – (a) before 
amplification and at concentration of 0.5 ng/µl – initial concentration of 
DNA at the start of amplification reaction, (b) before amplification and 
at concentration of 10 ng/µl, (c) after amplification. 
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Illustra Ready-To-Go GenomiPhi V3 DNA Amplification Kit was selected for DNA 
amplification. In order to test its performance, the genomic DNA from E. coli strains 
C41(DE3) and DH5α was amplified, according to manufacturer’s instructions, and the 
products of the amplification reactions were analysed using gel electrophoresis 
(Figure 4.3). The results show that using the discussed kit and the corresponding 
experimental protocol, high concentrations of amplified genomic DNA can be obtained 
from very small amounts of template DNA (10 ng). 
 
Figure 4.4   Yield of genomic DNA amplification carried out at different 
concentrations of MnCl2. Genomic DNA was extracted from E. coli 
C41(DE3). 
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It was also briefly investigated whether it is possible to perform random mutagenesis of 
genomic DNA during amplification. As such, the amplification reaction was carried out 
in the presence of different concentrations of magnesium chloride, MnCl2.  The results 
show that concentration of 0.5 mM MnCl2 does not have a significant effect on the 
amplification (Figure 4.4). However, for 1.5 mM MnCl2 noticeable decrease in the total 
amount of amplification product is observed, implying that Phi29 polymerase (present 
in Illustra Ready-To-Go GenomiPhi V3 DNA Amplification Kit) was affected by the 
presence of the added chemical. Addition of 3 mM MnCl2 completely inhibits the 
amplification. The obtained results are consistent with results published in scientific 
literature (Fujii et al., 2004, 2006). 
 
Figure 4.5   Amplified genomic DNA (1a) before and (1b) after purification with 
QIAquick PCR Purification Kit. Genomic DNA was extracted from 
E. coli C41(DE3). 
The applicability of standard column-based DNA purification to amplified genomic 
DNA was also investigated (Figure 4.5). Significant decrease in the overall product 
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concentration was observed after purification. This observation was confirmed by DNA 
concentration measurements using NanoDrop. Based on the experimental results, it was 
decided that DNA purification using membrane-based columns is not suitable for 
purification of genomic DNA amplified using illustra Ready-To-Go GenomiPhi V3 
DNA Amplification Kit and ethanol precipitation has to be used for this purpose. 
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4.4 DNA fragmentation 
The method of choice for fragmentation of genomic DNA is NEBNext dsDNA 
Fragmentase, enzyme mixture developed and sold by New England Biolabs, capable of 
generating breaks in double stranded DNA in a time-dependent manner. The main 
advantage of Fragmentase in comparison to competing methods is its general 
accessibility – the use of a different method, such as a nebuliser, could significantly limit 
the overall accessibility of Multi-Genius. 
 
Figure 4.6   Optimisation of DNA fragmentation. Yield of Fragmentase reaction for: 
(A) varying incubation time, and (B) different enzyme concentration 
while the incubation is set to 10 min. 
According to manufacturer’s instructions, genomic DNA was incubated with 
Fragmentase for varying time (10-20 min) to find optimal reaction conditions for 
achieving the desired size distribution (1-2 kb). The results show that even when the 
minimum recommended incubation time of 10 min is used the produced fragments are 
A B
  
 
| 159 | 
too short for the desired application. As using the incubation lower than 10 minutes 
could decrease the reproducibility of the fragmentation (due to irregularities in a way the 
reaction is stopped) , it was decided that instead of shortening the incubation time 
below 10 minutes lower concentration of the enzyme will be used. Based on the 
conducted experiment, it was demonstrated that 10 min incubation with 0.4-0.5 of the 
recommended enzyme concentration provides the optimal results. 
It should be noted that gel extraction will be employed after genomic DNA 
fragmentation to  isolate only the DNA fragments of the desired length (1-2 kb range). 
As a result, the observed wide size distribution while certainly not welcomed should not 
constitute a major problem in the following stages of Multi-Genius.  
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4.5 Vector design and construction 
The expression vector containing two cloning sites with different inducible promoters is, 
undoubtedly, the cornerstone of the whole project. As such, a lot of thought was put 
into its design and construction. Several important decision had to made: 
- selection marker – kanamycin was chosen as it is the most widely used antibiotic when 
it comes to protein expression, owing to its reliability and relative stability. 
 - plasmid copy number – origin of replication conferring a high copy number (pUC; 
copy number > 400) was selected to ensure that the cells will produce enough plasmid 
for the susequent genetic manipulation. It should be noted that high copy number can 
cause a significant metabolic burden when encoded protein is being expressed. However, 
this effect can be potentially offset by regulating the inducer concentration for the two 
promoters. 
- promoters – the primary characteristic of the two promoters should be their 
orthogonality, i.e., when one promoter is being induced, the second promoter should 
not be affected.   IPTG-inducible, T5 promoter and rhamnose-inducible promoter, 
Prham, are reported to being orthogonal (ATUM, 2017). Looking at the information 
gathered in section 1.4, the two promoters seem to a suitable choice for the given 
application. 
As the vector with aforementioned design criteria did not exist, it needed to be 
constructed by combining at least two DNA fragments. The good choice of vector 
backbone has been pD441-SR, 4 kb vector sold by ATUM that contains T5 promoter, 
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kanamycin resistance gene and the desired origin of replication (Figure 4.7). What is 
more, the vector is delivered in a linearised form, simplifying the subsequent molecular 
assembly. 
 
Figure 4.7   Outline of pD441-SR, used as a first building block for the assembly of 
Multi-Genius expression vector. 
The second DNA fragment needs to contain a cloning site under a control of rhamnose-
inducible promoter. Utilising the information about Expresso Rhamnose Cloning & 
Expression System (Lucigen, 2016), such DNA fragment was designed and synthesised 
by GeneScript. The fragment contained restriction sites complementary to the linearised 
pD441-SR (Figure 4.8). To perform the molecular assembly, the fragment was digested 
with corresponding restriction enzyme (SapI) and joined with the pD441-SR vector 
using traditional ligation and used for subsequent chemical transformation. The 
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resultant expression vector is presented in Figure 4.9. The successful integration was 
confirmed by sequencing of the isolated plasmid. 
 
Figure 4.8   530 bp DNA fragment containing the cloning site under a control of 
rhamnose-inducible promoter, used as the second building block for the 
assembly of Multi-Genius expression vector. 
 
 
Figure 4.9   Outline of the Multi-Genius expression vector, containing two cloning 
sites under the control of T5 and rhamnose-inducible promoter. 
ATCCGCTGAGGAGGTAAAAAGCTCTTCT│ATGTAAGTAAGTAAGCTATGGAGGTCAGGTATGATTTAAATGGTGACTCCTGTTGATAGATCCAGTAATGACCTCA
GAACTCCATCTGGATTTGTTCAGAACGCTCGGTTGCCGCCGGGCGTTTTTTATTGGTGAGAATCAGTATTGAGCGATATCTAGAGAATTCGTCCACCACAATTCAG
CAAATTGTGAACATCATCACGTTCATCTTTCCCTGGTTGCCAATGGCCCATTTTCCTGTCAGTAACGAGAAGGTCGCGAATTCAGGCGCTTTTTAGACTGGTCGTA
GGGAGACCACAACGGTTTCCCTCTAGAAATAATTTTGTTTAACTATAAGAAGGAGATATACATATGTAATTAGCTGAAGGGAAAGCCGCCACCGCTGAGCAATAA
CTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGGTAACGA│GGTAGAAGAGCTGAGGTCTCACCCC
AAGGGC 
SapI RS triple stop codon
λ t0 terminator
PRham promoter
triple stop codon
SapI RSRhamnose terminator
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4.6 Molecular cloning 
The process of optimising molecular cloning was undoubtedly the most time-consuming 
part of the whole development of Multi-Genius. As the sequence of the integrated DNA 
fragments is unknown, when cloning genomic libraries, most of the reported cloning 
method are unsuitable for this application. Also, due to the unknown nature of the 
cloned DNA sequence, half of the transformants, produced via any of the applicable 
methods, will contain a gene integrated in a opposite orientation.  
At first glance, three main methods of molecular cloning are available: TA cloning, use 
of DNA adapters and blunt-end cloning. Examining more closely the design of Multi-
Genius, TA cloning seem to be unsuitable due to a difficulty of introducing T-
overhangs into the second cloning site (once the first fragment has bee integrated). Due 
to a perceived complexity of utilising the adapters, the blunt-end ligation became the 
method of choice. Outline of the designed cloning strategy is presented in Figure 4.10.  
To assess the functionality of the designed strategy, it was decided that it will be used to  
clone a pool of EGFP genes into one cloning site and RFP into the second one. In this 
way, the cloning efficiency should be easy to quantify when the transformed cells are 
plated on agar plates supplemented with IPTG and rhamnose. 
In the early stages of the method optimisation, the fraction of the colonies exhibiting 
RFP or EGFP fluorescence was less than 1% using a standard blunt-end ligation 
protocol (the maximum number is 50%). 
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Figure 4.10   Outline of the cloning strategy for Multi-Genius, as shown on the 
example of (A) integrating egfp gene into cloning site number, and (B) 
subsequent integration of rfp gene into cloning site number 1. 
(*) denotes phosphorylated oligonucleotides. 
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Various different strategies were tested in order to increase overall cloning efficiency. In 
the end, four strategies contributed to achieving transformation efficiency close to 50% 
and increasing the overall reproducibility: 
- the number of doublings in the PCRs used to linearise the vector was decreased, 
by increasing the initial vector concentration and lowering the number of cycles 
from 25 to 30. This should lower, in the process, the chances of incorporating 
random mutations into the vector backbone during amplification. 
- the primers used for vector linearisation were HPLC purified as truncated 
oligonucleotides seemingly interfered with subsequent blunt-end ligation. 
- the linearised vector was dephosphorylated before the blunt-end ligation. At first 
glance, the linearised vector should not contain 5’-phosphate as it is a product of 
a PCR with unmodified oligonucleotides. However, the inclusion of the 
dephosphorylation step significantly increased the cloning efficiency. 
- the reaction parameters of blunt-end ligation were optimised. Some of the 
important changes to the protocol include: increasing the ligase concentration 
four times, inclusion of polyethylene glycol in the reaction mixture and 
increasing the insert and vector concentration two times. 
All in all, the initial cloning protocol was significantly altered to increase the overall 
transformation efficiency. The optimised protocol was utilised to incorporate RFP 
and EGFP genes into Multi-Genius expression vector.  
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Figure 4.11   The result of applying optimised cloning protocol for incorporating two 
genomic libraries into Multi-Genius vector via blunt-end ligation; the 
integration of the first fragment. The RFP and EGFP represent the two 
libraries. The achieved transformation efficiencies are given on the right. 
 
Table 4.2   The result of applying optimised cloning protocol for incorporating two 
genomic libraries into Multi-Genius vector via blunt-end ligation; the 
integration of the first fragment (presented in Figure 4.11) – achieved 
number of transformants. 
 
 
EGFP RFP
PT5 4·105 105
Prham 106 6·105
Transformation efficiency: 5·108 cfu/µg
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Firstly, each of the two fluorescent proteins was integrated into each cloning site – 
resulting in four combinations (EGFP/CS1, EGFP/CS2, RFP/CS1 and RFP/CS1). The 
results are presented in Figures 4.11 and Table 4.2. The results clearly demonstrate an 
excellent performance of the developed protocol. It should be noted that transformation 
efficiency of more than 50% is, most likely, caused by a poor growth of cells containing 
the inverted EGFP and RFP genes, due to potential misfolding and formation of 
inclusion bodies.  
 
Figure 4.12   Plasmids extracted from four different population cells resulting 
from applying the optimised cloning protocol to integrate: (1) 
EGFP into cloning site 1,  (2) RFP into cloning site 1, (3) EGFP 
into cloning site 1, and (4) RFP into cloning site 2. 
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To further investigate the efficiency of the method, plasmids extracted from each 
population were analysed on agarose gel (Figure 4.12). The gel image shows quite clearly 
that the vast majority of plasmids, and consequently the transformants, contain an 
insert. What is more, the number of plasmids containing more than one insert is 
negligible. 
 Subsequently, the optimised protocol was used to integrate RFP into cloning site 2 of 
EGFP/CS1 plasmid mixture and EGFP into cloning site 2 of RFP/CS1 plasmid 
mixture. The results are presented in Figure 4.13. Once again, the cloning efficiency 
proved to be very high.  
 
 
Figure 4.13   The result of applying optimised cloning protocol for 
incorporating two genomic libraries into Multi-Genius vector via 
blunt-end ligation; the integration of the second fragment. The 
RFP and EGFP represent the two libraries. 
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4.7 Methods 
4.7.1 Materials 
All enzymes, deoxyribonucleotides and DNA ladders were purchased from New 
England Biolabs (Ipswich, USA). 
4.7.2 Primers 
Primers used in this study were synthesized by Eurofins Genomics (Ebersberg, 
Germany). Melting temperatures of oligonucleotides were determined using the New 
England Biolabs Tm Calculator (https://www.neb.com/tools-and-resources/interactive-
tools/tm-calculator). To amplify EGFP and RFP fragments the following four primers 
were used: 
EGFP_Fwd_2 (5’- GTGAGCAAGGGCGAGG -3’; 16 bp) 
EGFP-Rev (5’-TTACTTGTACAGCTCGTCCATG-3’, 22 bp)  
RFP_Fwd_2 (5’- GCGAGTAGCGAAGACGTTATCAAAGAG -3’; 27 bp) 
RFP-Rev (5’-TTAAGCACCGGTGGAGTGACG-3’, 21 bp) 
The primers were phosphorylated by T4 Kinase and subsequently purified with 
QIAquick Nucleotide Removal Kit (Qiagen). 
To linearise Multi-Genius expression vector, the following four HPLC-prurified primers 
were used: 
Int_CS1_a_HPLC (5’- CATTTTTTACCTCCTTAAAAG-3’; 21 bp) 
Int_CS1_b_HPLC (5’- TAAGTAAGTAAGCTATGGAG -3’; 20 bp) 
Int_CS2_a_HPLC (5’- CATATGTATATCTCCTTCTTATAGTTAAAC -3’; 30 bp) 
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Int2_CS2_b_HPLC (5’- TAATTAGCTGAAGGGAAAGC -3’; 57 bp) 
4.7.3 Genomic DNA extraction 
Genomic DNA was extracted using Bacterial DNA Kit from OMEGA Bio-Tek, in 
accordance with manufacturer’s instructions. 
4.7.4 Genomic DNA amplification 
Extracted genomic DNA was amplified using illustra Ready-To-Go GenomiPhi V3 
DNA Amplification Kit, in accordance with manufacturer’s instructions. 
4.7.5 DNA fragmentation 
Genomic DNA was fragmented using Fragmentase from NEB, in accordance with 
manufacturer’s instructions. To achieve the desired size distribution, 20µl reaction 
mixtures were prepared, containing: 1X Fragmentase Reaction Buffer, up 3 µg of 
genomic DNA and 0.8 µl of Fragmentase. The reaction mixture was incubated for 
10 min at 37°C. After 10 min, the reaction was stopped by adding 5 μl of 0.5 M EDTA. 
4.7.6 Vector construction 
Linearised pD441-SR vector was ordered from ATUM and 530 bp DNA insert was 
synthesised by GeneScript. The DNA fragment was digested overnight with SapI 
restriction enzyme. The restriction enzyme was deactivated by 20 min incubation 
at 65°C. The two fragments were assembled together in 20 µl reaction mixture 
containing: 1X T4 DNA Ligase Buffer , 0.02 pmol of linearised pD441-SR vector, 
0.06 pmol of the insert and 1 µl T4 DNA ligase. The ligation mixture was incubated 
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overnight at 16°C. 5 µl of the ligation mixture was for chemical transformation of E. coli 
DH5α. The presence of the insert was confirmed by sequencing. 
4.7.7 DNA cloning 
To amplify EGFP gene, PCR mixture (50 µl) containing 1× Q5 Reaction Buffer, 200 
µM of each dNTP, 500 nM phosphorylated EGFP_Fwd_2 primer, 500 nM EGFP-Rev 
phosphorylated primer, 0.2 ng pEGFP, and 1 U Q5 High-Fidelity DNA Polymerase 
was thermocycled using the following programme: (i) 30 s initial denaturation at 98°C, 
(ii) 30 cycles of 7 s denaturation at 98°C, 20 s annealing at 65°C and 30 s extension at 
72°C and (iii) 2 min final extension at 72°C. The PCR product was purified using 
QIAquick PCR Purification Kit and its DNA concentrations was determined using 
VersaWave (Expedeon). 
To amplify RFP gene, PCR mixture (50 µl) containing 1× Q5 Reaction Buffer, 200 µM 
of each dNTP, 500 nM phosphorylated RFP_Fwd_2 primer, 500 nM RFP-Rev 
phosphorylated primer, 0.2 ng pBbA8k-RFP, and 1 U Q5 High-Fidelity DNA 
Polymerase was thermocycled using the following programme: (i) 30 s initial 
denaturation at 98°C, (ii) 30 cycles of 7 s denaturation at 98°C, 20 s annealing at 70°C 
and 30 s extension at 72°C and (iii) 2 min final extension at 72°C. The PCR product 
was purified using QIAquick PCR Purification Kit and its DNA concentrations was 
determined using VersaWave (Expedeon). 
To linearise Multi-Genius expression vector at the cloning site 1 (under the control of 
T5 promoter), PCR mixture (50 µl) containing 1× Q5 Reaction Buffer, 200 µM of each 
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dNTP, 500 nM Int_CS1_a_HPLC primer, 500 nM Int_CS1_b_HPLC primer, 1 ng 
Multi-Genius expression vector, and 1 U Q5 High-Fidelity DNA Polymerase was 
thermocycled using the following programme: (i) 30 s initial denaturation at 98°C, (ii) 
24 cycles of 7 s denaturation at 98°C, 20 s annealing at 55°C and 2 min 15 s extension 
at 72°C and (iii) 4 min final extension at 72°C. . Forty units of DpnI were subsequently 
added to the PCR mixture and incubated at 37ºC for 1 h to remove template DNA. 
The PCR product was purified using QIAquick PCR Purification Kit and its DNA 
concentrations was determined using VersaWave (Expedeon). 
To linearise Multi-Genius expression vector at the cloning site 2 (rhamnose-inducible), 
PCR mixture (50 µl) containing 1× Q5 Reaction Buffer, 200 µM of each dNTP, 500 
nM Int_CS2_a_HPLC primer, 500 nM Int_CS2_b_HPLC primer, 1 ng Multi-Genius 
expression vector, and 1 U Q5 High-Fidelity DNA Polymerase was thermocycled using 
the following programme: (i) 30 s initial denaturation at 98°C, (ii) 24 cycles of 7 s 
denaturation at 98°C, 20 s annealing at 60°C and 2 min 15 s extension at 72°C and (iii) 
4 min final extension at 72°C. . Forty units of DpnI were subsequently added to the 
PCR mixture and incubated at 37ºC for 15 min to remove template DNA. The PCR 
product was purified using QIAquick PCR Purification Kit and its DNA concentrations 
was determined using VersaWave (Expedeon). 
The linearised vector was dephosphorylated by incubation Shrimp Alkaline Phosphatase 
(rSAP) for 1.5 h at 37°C. To inactivate the enzyme, the mixture was subsequently 
heated to 65°C for 15 min. 
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The linearised vector and the inserts encoding for the two fluorescent were assembled 
together in 20 µl ligation mixtures containing: 1X T4 DNA Ligase Buffer, 6.8% 
PEG6000, 7.5% 1,2-propanediol, 0.04 pmol of linearised vector, 0.12 pmol of the 
insert and 1,600 U T4 DNA ligase. The ligation mixture was incubated at 16°C for 4 h. 
Afterwards, the ligation mixture was purified and concentrated to 5 µl using DNA 
Clean & Concentrator™-5 (Zymo Research). 
E. coli DH5α was transformed via electroporation with 4 µl of the resultant ligation 
mixture (purified). Transformed cells were plated on  LB agar plates (10 g/l tryptone, 5 
g/l yeast extract, 10 g/l sodium chloride and 15 g/l agar) supplemented with: 50 µg/ml 
kanamycin, 1 mM IPTG and/or 0.2% (w/v) rhamnose. 
4.7.8 DNA gel electrophoresis 
PCR  products were analyzed using either 0.7% agarose gel. For visualisation purposes, 
ethidium bromide was added to the gel. Quick-Load 1 kb DNA Ladder was used as a 
DNA ladder. 
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5.1 Expression studies 
To further investigate the functionality of the developed method, after performing 
EGFP and RFP cloning experiments summarised in Section 4.6, two plasmids, 
exhibiting the simultaneous expression of both fluorescent proteins, were picked at 
random and the two plasmid were isolated: CS1:EGFP/CS2:RFP and 
CS1:RFP/CS2:EGFP, where CS1 denotes cloning site 1 under the control of T5 
promoter and CS2 represents the rhamnose-inducible cloning site. Firstly, both cloning 
sites in the two plasmids were sequenced and it was confirmed that the two fluorescent 
proteins were seamlessly integrated into the vector. 
To investigate the orthogonality of the two cloning sites, the two vectors were cultured 
with different configurations of the two inducers – rhamnose and IPTG. The resultant 
cell pellets were carefully inspected and the fluorescence corresponding to EGFP and 
RFP expression was also measured (Figures 5.1 and 5.2; Tables 5.1 and 5.2).. 
All in all, the result are quite promising and the expression vector seems to be working as 
intended. However, some rather unexpected observations need to be noted.    
It appears that when two proteins are being co-expressed, the fluorescence of RFP 
significantly exceeds the fluorescence of the EGFP. At first glance, it might be assumed 
that the two proteins are present at fairly similar amounts and the observed discrepancy 
is caused by the difference in their brightness or an overlap of their emission-absorption 
spectra. However, the brightness of EGFP is three times higher than RFP (Campbell et 
al., 2002; NIC_Wiki, 2017) and the potential effects of spectral overlap seem to be 
insufficient to account for such a significant difference.   
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Figure 5.1  Cell pellets of CS1:EGFP/CS2:RFP-transformed cells after incubation 
for 12 h (at 37°C and 500 rpm) in LB media supplemented with: (1) 
kanamycin only, (2) Kan + 2% glucose, (3) Kan + 1mM IPTG, (4) Kan 
+ 0.2% L-rhamnose, and (5) Kan + 1 mM IPTG + 0.2% L-rhamnose.  
(-ve) denotes cell pellet of DH5α cells with no plasmid. 
 
Table 5.1  Fluorescence of CS1:EGFP/CS2:RFP-transformed cells after incubation 
for 12 h (at 37°C and 500 rpm) in LB media supplemented with: (1) 
kanamycin only, (2) Kan + 2% glucose, (3) Kan + 1mM IPTG, (4) Kan 
+ 0.2% L-rhamnose, and (5) Kan + 1 mM IPTG + 0.2% L-rhamnose. 
 
λexc/λem [nm] 
Fluorescence [103 RFU] 
(1) (2) (3) (4) (5) 
488/509 (EGFP) 0.44 0.05 16.29 0.13 3.83 
584/607 (RFP) 0.10 0.11 1.58 13.64 14.10 
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Figure 5.2  Cell pellets of CS1:RFP/CS2:EGFP-transformed cells after incubation 
for 12 h at (37°C and 500 rpm) in LB media supplemented with: (1) 
kanamycin only, (2) Kan + 2% glucose, (3) Kan + 1 mM IPTG, (4) Kan 
+ 0.2% L-rhamnose, and (5) Kan + 1 mM IPTG + 0.2% L-rhamnose.  
(-ve) denotes cell pellet of DH5α cells with no plasmid. 
 
 
Table 5.2  Fluorescence of CS1:RFP/CS2:EGFP-transformed cells after incubation 
for 12 h at (37°C and 500 rpm) in LB media supplemented with: (1) 
kanamycin only, (2) Kan + 2% glucose, (3) Kan + 1 mM IPTG, (4) Kan 
+ 0.2% L-rhamnose, and (5) Kan + 1 mM IPTG + 0.2% L-rhamnose. 
 
λexc/λem [nm] 
Fluorescence [103 RFU] 
(1) (2) (3) (4) (5) 
488/509 (EGFP) 0.05 0.04 0.11 17.80 1.21 
584/607 (RFP) 0.55 0.10 14.27 0.05 12.87 
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It is rather the case that when the two proteins are being co-expressed the rate of EGFP 
expression is much lower than RFP. A situation when the expression of one protein 
overtakes the second one (leading to its poor expression) during co-expression, even 
when the two protein are well expressed in isolation, has been reported in literature 
(Diatchenko et al., 1996). This phenomenon has been attributed to different 
translational rates between the two proteins (Novagen, 2011). This is in complete 
agreement with the investigated situation, as the utilised EGFP gene has been optimised 
for expression in mammalian cells and due to the presence of rare codons its 
translational rate should be much lower than RFP optimised for expression in E. coli. 
The second observation is that in the absence of its repressor, glucose, T5 promoter seem 
to be slightly leaky as seen by a slight RFP expression in Figure 5.2 when no inducer is 
added (1). 
Finally, the transcription terminator between the cloning site seem to be imperfect as 
seen by a noticeable expression of RFP when IPTG is added to CS1:EGFP/CS2:RFP-
transformed cells (Table 5.1). 
Further expression studies were conducted, to investigate expression profile with respect 
to varying concentration of one inducer (Figures 5.3-5.6). The results show that the 
expression from the two promoters is titratable over a nearly 5 fold expression range. In 
addition, the observation about the imperfect transcription terminator was further 
confirmed – resulting in unwanted expression from the second cloning site, when the 
first one is induced (Figure 5.3). 
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Figure 5.3  Fluorescence of CS1:EGFP/CS2:RFP-transformed cells after 12 h 
incubation with different concentration of IPTG. Green line denotes 
EGFP (λexc = 488 nm ; λem = 509 nm) and red line corresponds to RFP 
(λexc = 584 nm ; λem = 607 nm). First chart - linear scale; second chart – 
logarithmic scale. 
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Figure 5.4  Fluorescence of CS1:EGFP/CS2:RFP-transformed cells after 12 h 
incubation with different concentration of L-rhamnose. Green line 
denotes EGFP (λexc = 488 nm ; λem = 509 nm) and red line corresponds 
to RFP (λexc = 584 nm ; λem = 607 nm). First chart - linear scale; second 
chart – logarithmic scale. 
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Figure 5.5  Fluorescence of CS1:RFP/CS2:EGFP-transformed cells after 12 h 
incubation with different concentration of IPTG. Green line denotes 
EGFP (λexc = 488 nm ; λem = 509 nm) and red line corresponds to RFP 
(λexc = 584 nm ; λem = 607 nm). First chart - linear scale; second chart – 
logarithmic scale. 
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Figure 5.6  Fluorescence of CS1:RFP/CS2:EGFP-transformed cells after 12 h 
incubation with different concentration of L-rhamnose. Green line 
denotes EGFP (λexc = 488 nm ; λem = 509 nm) and red line corresponds 
to RFP (λexc = 584 nm ; λem = 607 nm). First chart - linear scale; second 
chart – logarithmic scale. 
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5.2 Method application 
5.2.1 Thermotolerance and halotolerance of E. coli DH5α  
To demonstrate the usefulness of Multi-Genius, it was decided that the method will be 
used to identify novel genes encoding for thermotolerance and halotolerance, in order to 
develop these traits in E. coli DH5α. 
In order to identify improved variants and choose the right selective conditions, intrinsic 
resistance of E. coli DH5α to high temperatures and high sodium chloride concentration 
was investigated. To do so, E. coli was cultured in a form of spot plates at different 
temperatures and sodium chloride concentrations. The results of these experiments are 
presented in Figure 5.7 and 5.8. 
 
Figure 5.7 Natural thermotolerance of E. coli DH5α - the photographs of E. coli 
spots incubated on LB agar plates for 24 h at different temperatures. 
Each spot was made with 2.5 µl of cell suspension of  E. coli cells grown 
to OD600 of 0.5 or its appropriate dilution. 
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Figure 5.8 Natural halotolerance of E. coli DH5α - the photographs of E. coli spots 
incubated for 24 h on LB agar plates supplemented with different 
concentrations of sodium chloride. Each spot was made with 2.5 µl of 
cell suspension of  E. coli cells grown to OD600 of 0.5 or its appropriate 
dilution. 
It should be noted that that for both high sodium chloride concentration and high 
temperature there is no clear cut-off point after crossing of which all the cells suddenly 
stop propagating. It is rather the case that due to a natural ability of microorganism to 
evolve, the survivability of E. coli DH5α gradually decreases with higher temperature 
and higher sodium chloride concentration.  
It is worth noting that after several days of storing the plates at room temperature, two 
previously not visible colonies grew on the 8% NaCl agar plate. It was later confirmed 
that these two colonies are not caused by a contamination and the obtained result is 
reproducible (when high number of cells is plated on the 8% NaCl agar plate). This 
observation shows the importance of designing and implementing proper controls 
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during the subsequent screening experiments (due to a possibility of obtaining false 
positives). 
5.2.2 Application 
To identify novel genes encoding for thermotolerance and halotolerance, three 
organisms were chosen as donors of the genomic DNA and a suitable target of the 
method. It was ensured that genomes of the selected organisms had been sequenced and 
the associated information is publicly available. 
The first organism is Thermus thermophilus, a Gram-negative bacteria and a model 
organism for genetic engineering, The microorganisms was originally isolated from 
thermal vents and grows optimally at 65°C. One concern regarding this organism, is 
that its genes might be difficult to express in E. coli due to a significant differences 
between optimal growth temperature of the two organisms. 
As a result, the second selected organism is Bacillus coagulans, a well-studied Gram-
positive bacteria and obligate thermophile – its optimal growth temperature is 50°C, 
however, the organisms is capable of tolerating temperatures in the range of 30-55°C.  
To help evolve halotolerance in E. coli, the genomic DNA from Chromohalobacter 
salexigens was utilised. This gram-negative bacterium is capable of surviving a wide range 
of salt concentrations.  
Genomic DNA from the three organisms was ordered from German Collection of 
Microorganisms and Cell Cultures GmbH, DSMZ. 
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Including the genomic DNA extracted from E. coli DH5α, this constitutes four sources 
of genomic libraries – three for evolving thermotolerance and two for halotolerance 
(genomic DNA extracted from E. coli DH5α can be used for both experiments). 
The details of the conducted experiment are presented in Table 5.3 It should be noted 
that all the individual screenings presented in Table 5.3 were conducted concurrently. 
Table 5.3  The outline of the experiment using Multi-Genius to identify novel 
genes encoding for thermotolerance and halotolerance. CS1 denotes the 
genomic library integrated into the first cloning site (under the control 
of T5 promoter) and CS2 denotes genomic library integrated into the 
second cloning site (rhamnose-inducible). In the case of C. salexigens and 
E. coli the integration of the fragmented genomic library was performed 
twice resulting in two unique set of libraries per organism. 
Experiment no. CS1 CS2 Selective condition 
1 T. thermophilus B. coagulans 46°C 
2 B. coagulans B. coagulans 46°C 
3 T. thermophilus T. thermophilus 46°C 
4,5 E. coli DH5α E. coli DH5α 46°C 
6,7 C. salexigens C. salexigens 6.5 and 8% NaCL 
8.9 E. coli DH5α E. coli DH5α 6.5 and 8% NaCL 
Control egfp rfp All of the above 
 
After integrating the genomic library into the second cloning site and performing 
electroporation, the transformants were grown on LB plates supplemented with 
kanamycin, IPTG and rhamnose, and subjected to selective conditions described in 
Table 5.3. The results of the experiment are summarised in Table 5.4. 
 
  
 
| 187 | 
Table 5.4  The results of the experiment of using Multi-Genius to identify novel 
genes encoding for thermotolerance and halotolerance. Library size is the 
same as transformation efficiency for a given experiment. 
Experiment no. Library size Observed colonies 
1 3·106 254 
2 7·105 58 
3 2·106 0 
4 9·104 24 
5 2·105 12 
6 2·106 0 
7 2·105 0 
8 9·104 0 
9 2·105 0 
Control - 0 
 
In short, no colonies were observed on agar plates supplemented with increased salt 
concentration, making the attempt of isolating halotolerant variant unsuccessful. 
Also, the cells containing the plasmid with genomic libraries from T. thermophilus 
resulted in no colonies. As it was already discussed, the potential cause might be poor 
protein expression. 
All in all, however, the usefulness of the method was clearly demonstrated by isolating 
thermotolerant variants containing genomic fragments from E. coli, T. thermophilus and 
B. coagulans. In addition, a significantly more colonies were observed on the plates 
associated with B. coagulans  than E. coli. This proves the hidden potential of screening 
organisms other than E. coli, even when the ultimate goal is evolve a phenotype in this 
organism. 
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5.2.3 Further characterisation 
60 bacterial variants exhibiting an improved thermotolerance were picked from the four 
plates exhibiting an observable colony growth at 46°C (Experiments 1, 2, 4 and 5). To 
further characterise them, their growth rate was measured in a 96-well plate and 
compared to cells containing an empty Multi-Genius vector, which act as a negative 
control (for more details on the experimental procedure, see Section 5.4.8). 
The initial experimental design involved growing the cells in a media supplemented with 
different combinations of the two inducers at 46°C (the four combinations being: no 
inducer, IPTG only, L-rhamnose only and both inducers) and comparing the bacterial 
growth under these conditions. Such experimental setup should not only confirm the 
improvement in thermotolerance but also determine, for each isolated variant, which 
genomic insert (or both) is responsible for the observed phenotype (depending on which 
combination of the two inducers results in the improved thermotolerance). In this way, 
the usefulness of modular expression employed in Multi-Genius would be clearly 
demonstrated. 
Unfortunately, temporal and spatial variations of the temperature within the shaking 
incubators (deriving from the limitations of the equipment) interfered with an accurate 
measurement of bacterial growth rate at 46°C. At this temperature, even small variations 
in the temperature (<0.5°C) lead to relatively large differences in the growth rate. As no 
statistically-significant difference between the four conditions could be readily observed 
in this scenario, the final results are presented as a mean value of the optical density 
measured for the four conditions. As each condition was performed in two replicates, 
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the optical density, presented in Table 5.5, is a mean value of eight data points. By 
averaging individual values, the effect of spatial variation of the temperature (within two 
incubators used for the experiment) was minimised and the accuracy of the final results 
was significantly increased.  
Table 5.5  Mean optical density of the 60 isolated thermotolerant variants measured 
after 8 h of exponential growth at 46°C, presented as a ratio of the 
optical density to the value obtained for E. coli cells containing an empty 
Multi-Genius vector (negative control). The results can be interpreted as 
a fold improvement in OD600 after 8 h exponential growth at 46°C. 
OD600 measured for the negative control was equal to 0.0085. Rows and 
columns describe a location within the 96 well-plate. 
 
Column 
2 3 4 5 6 7 8 9 10 11 
R
ow
 
B 15 25 22 11 9 20 17 8 23 23 
C 2 25 17 8 8 18 15 16 20 19 
D 34 12 14 10 24 8 19 12 25 19 
E 19 18 10 8 6 19 22 22 14 18 
F 21 22 8 19 12 20 23 14 20 19 
G 27 21 11 18 17 8 16 20 17 17 
 
The presented results clearly demonstrate a marked improvement in the growth rate of 
the isolated variants, as compared to the E. coli cells containing the empty Multi-Genius 
vector. After 8h of exponential growth, most of the isolated variants show at least 10-
fold improvement in the final optical density. 
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To confirm that the observed phenotype is really conferred by the inserts within the 
Multi-Genius vector and was not caused by a random mutation of endogenous genomic 
DNA during the selection process, the plasmids from 10 best-performing variants were 
isolated and used for transformation of native E. coli DH5α cells.  
The growth rate of these variants was measured in a similar fashion to the previous 
experiment (for more details on the experimental procedure, see Section 5.4.8). Once 
again, no statistically-significant difference between the four combinations of the 
inducer concentration could be readily observed. As such, the final results (shown in 
Table 5.6) are presented as an average value of the optical density measured for the four 
conditions. 
Table 5.6  Mean optical density of the E. coli DH5α transformed with the plasmids 
purified from the Multi-Genius experiment, measured after 8 h of 
exponential growth at 46°C. The results are presented as a ratio of the 
optical density to the value obtained for E. coli cells containing an empty 
Multi-Genius vector (negative control). The results can be interpreted as 
a fold improvement in OD600 after 8 h exponential growth at 46°C. 
OD600 measured for the negative control was equal to 0.0076. 
Variant OD600/OD600-ve [-] 
B2 26 
D2 29 
G2 30 
B3 29 
C3 26 
B4 28 
D6 27 
B10 27 
D10 28 
B11 27 
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Similarly to the previous experiment, the isolated variants showed a marked 
improvement in the growth rate at 46°C, as compared to the E. coli cells containing an 
empty Multi-Genius vector. Based on the presented results, it can be claimed with a 
high dose of confidence that the observed improvement in the thermotolerance is 
conferred by the inserts within the Multi-Genius vector. 
To further elucidate the mechanism behind the observed improvement in 
themotolerance, the inserts from the ten isolated plasmids were sequenced. The results 
are presented in Table 5.7. 
The sequencing results are somehow unexpected but, at the same time, consistent with 
the results of the previous experiments. All vectors corresponding to genomic DNA 
from B. coagulans contain the same gene (thyA), encoding for an enzyme thymidylate 
synthase. It should be noted that apart from variants B4 and D6, which contain 
identical inserts, the remaining variants appear to be unique library members. The fact 
that all of the selected variants feature the same gene, seems to suggest that it is integral 
to the investigated phenotype. What is more, thyA is also present in the Multi-Genius 
vectors constructed from genomic DNA of E. coli DH5α, further proving the 
significance of this gene for enhancing thermotolerance. Considering that the improved 
thermotolerance is observed even when the insert is integrated in a reverse orientation, it 
can be hypothesised that the expression of the gene relies on its native, constitutive 
promoter, which is recognised by E. coli DH5α transcription machinery. This 
observation explains the fact that during the previously-discussed bacterial growth 
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studies, no statistically-significant differences between the four combinations of the 
inducer concentration could be readily observed.  
Table 5.7  Sequencing results of the ten plasmids, isolated from Multi-Genius 
experiment, including the position of the insert within a bacterial 
chromosome (GenBank: CP025268.1 for E. coli and CP009709.1 for 
B. coagulans) and complete genes present within the fragment.  
Variant 
Cloning 
site 
gDNA source Start End 
Complete genes present on 
the insert 
B2 
1 E. coli DH5α 1,752,276 1,751,639 - 
2 E. coli DH5α 2,967,500 2,965,533 thyA, ppdA 
D2 
1 E. coli DH5α Unreadable sequence 
2 E. coli DH5α Unreadable sequence 
G2 
1 E. coli DH5α 2,967,473 2,966,501 thyA 
2 E. coli DH5α 2,697,068 2,698,441 none 
B3 
1 B. coagulans No insert - 
2 B. coagulans 273,837 272,408 thyA 
C3 
1 B. coagulans 454,191 453,077 BF29_449, BF29_450 
2 B. coagulans 273,786 272,770   thyA 
B4 
1 B. coagulans No insert - 
2 B. coagulans 273,784 272,578 thyA 
D6 
1 B. coagulans No insert - 
2 B. coagulans 273,784 272,578 thyA 
B10 
1 T. thermophilus No insert - 
2 B. coagulans 274,139 272,788 thyA, dfrA 
D10 
1 T. thermophilus No insert - 
2 B. coagulans 274,154 272,795 thyA, dfrA 
B11 
1 T. thermophilus No insert - 
2 B. coagulans 272,213 274,002 thyA 
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It should be noted that many of the sequenced plasmids contained only one insert. 
Considering that the observed improvement in the phenotype seems to be conferred by 
only one gene and the sequenced plasmids come from the variants exhibiting the 
highest growth rate at 46°C, it is not surprising that such selection pressure would 
favour the cells with only one functional insert. In other words, if the investigated 
phenotype is encoded by only one gene (within the space of investigated genomic 
DNA), the presence of additional insert (that does not confer the phenotype) places an 
extra metabolic burden on the cell. As such, most of the members of the starting library 
contain two inserts (as determined in Section 4.6) and only during the subsequent 
selection process library members with only one insert are preferentially enriched when 
a phenotype is encoded just by one gene. 
As thyA features in all nine variants that provided a readable DNA sequence, it can be 
said with a high dose of confidence that this gene is responsible for observed 
thermotolerance. Inside a cell, thymidylate synthase catalyses the conversion of 
deoxyuridine monophosphate to deoxythymidine monophosphate and, as such, is 
integral to DNA replication and overall cell growth. According to Stout et  al.,  
thymidylate synthase from E. coli functions as a homodimer with a melting temperature 
of 45.7°C (Stout et al., 1998).  
In light of the presented results and information, it can be hypothesised that 
thymidylate synthase constitutes a major bottleneck to thermotolerance of E. coli and its 
poor growth at 46°C can be explained by denaturation of a protein integral to DNA 
replication. This detrimental effect can be alleviated by either increasing the expression 
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level of the enzyme (as observed in isolated variants B2 and G2) or providing a more 
thermostable version of the enzyme (as observed in the seven isolated variants 
containing genomic DNA from B. coagulans). It would worthwhile to verify this 
hypothesis by cloning thyA into a common expression vector and conducting further 
characterisation studies. 
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5.3 Conclusion 
Multi-Genius expands upon the concept of genomic libraries to tap into naturally-
existing diversity and expedite identification of genes encoding for useful phenotypes. 
The method addresses significant limitations and lacking features in the area of 
identifying genes encoding for useful phenotypes. Multi-Genius expands the concept of 
screening multiple genes (in search of DNA fragments encoding for complex 
phenotypes) to genomic elements originating from exogenous genomic DNA.  
The potential of the method is demonstrated by isolating thermotolerant variants of 
Escherichia coli DH5α. The applicability of the method to acquisition of new biological 
parts is shown by identifying the major role of thyA (encoding for thymidylate synthase) 
in enhacing thermotolerance. Based on the presented results, it is hypothesised that 
natural thermotolerance of E. coli can be increased by either increasing the expression of 
the gene or substituting the enzyme with a more thermostable homologue. 
What is more, Multi-Genius utilises the concept of modular expression to address the 
problem of biological complexity. The use of two orthogonal, inducible promoters allow 
for studying the interplay between individual genetic elements and optimising the 
performance of the resultant biological system by fine-tuning the individual gene 
expression. Due to the intrinsic nature of the investigated system, the usefulness of this 
concept could not be properly showcased. However, it is believed that this integral 
feature will prove invaluable when applying Multi-Genius to a different system (namely, 
a different phenotype or source of genomic DNA is investigated).  
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All in all, Multi-Genius ties together different concepts and techniques associated with 
molecular biology to offer a streamlined protocol for uncovering new biological parts 
and studying interactions between distant genes. 
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5.4 Methods 
5.4.1 Materials 
All enzymes, deoxyribonucleotides and DNA ladders were purchased from New 
England Biolabs (Ipswich, USA). 
5.4.2 Primers and genomic DNA 
Primers used in this study were synthesized by Eurofins Genomics (Ebersberg, 
Germany). Melting temperatures of oligonucleotides were determined using the New 
England Biolabs Tm Calculator (https://www.neb.com/tools-and-resources/interactive-
tools/tm-calculator). 
To linearise Multi-Genius expression vector, the following four HPLC-purified primers 
were used: 
Int_CS1_a_HPLC (5’- CATTTTTTACCTCCTTAAAAG-3’; 21 bp) 
Int_CS1_b_HPLC (5’- TAAGTAAGTAAGCTATGGAG-3’; 20 bp) 
Int_CS2_a_HPLC (5’- CATATGTATATCTCCTTCTTATAGTTAAAC-3’; 30 bp) 
Int2_CS2_b_HPLC (5’- TAATTAGCTGAAGGGAAAGC-3’; 57 bp) 
For sequencing of the two cloning sites of the Multi-Genius expression vector, the 
following four primers were used: 
CS1_Seq_Fwd (5’- GAGCGGATAACAATTACGAGC-3’; 21 bp) 
CS1_Seq_Rev (5’- AATCCAGATGGAGTTCTGAGG-3’; 21 bp) 
CS2_Seq_Fwd (5’- GTCAGTAACGAGAAGGTCG-3’; 19 bp) 
CS1_Seq_Rev (5’- CAAATAAAACGAAAGGCTCAGTCG-3’; 24 bp) 
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Genomic DNA from the following bacterial strains - Bacillus coagulans ATCC 7050 
(DSM no. 1), Thermus thermophilus HB8 (DSM no. 579) and Chromohalobacter 
salexigens 1H11 (DSM no: 3043) – was purchased from German Collection of 
Microorganisms and Cell Cultures GmbH (DSMZ). 
5.4.3 Initial expression studies 
50 µl aliquots of overnight culture from both CS1:EGFP/CS2:RFP and 
CS1:RFP/CS2:EGFP-containing cells were used to inoculate 5 ml aliquots of LB media 
supplemented with: (1) kanamycin only (50 μg/ml), (2) kanamycin and 2% (w/v) 
glucose, (3) kanamycin and 1 mM IPTG, (4) kanamycin and 0.2% (w/v) L-rhamnose 
and (5) kanamycin, 1 mM IPTG and 0.2% (w/v) L-rhamnose. The cells were grown for 
12 h at 37°C with shaking (500 rpm).  
3 ml aliquots of cell cultures were pelleted by centrifugation in 1.5 ml microcentrifuge 
tubes (supernatant was carefully removed by pipetting). The photographs of the pellets 
were taken under visible or UV light.  
200 µl aliquots of cell suspension were used for fluorescent measurements using 
SpectraMax M2e Multi-Mode Microplate Reader (Molecular Devices) using the 
following settings: 
- EGFP – excitation wavelength: 488 nm; emission wavelength: 509 nm 
- RFP – excitation wavelength: 584 nm; emission wavelength: 607 nm 
Cell suspension of wild-type DH5α cells (containing no plasmid) were used as a blank 
solution. 
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5.4.4 Further expression studies 
5 µl aliquots of overnight culture from both CS1:EGFP/CS2:RFP and 
CS1:RFP/CS2:EGFP-containing cells were used to inoculate 0.5 ml aliquots of LB 
media (supplemented with 50 μg/ml kanamycin and varying concentration of the two 
inducers) present in individual wells of a 96-deep-well plate.  CS1:EGFP/CS2:RFP-
containing cells were used to inoculate: (1) 12 wells containing 1:2 serial dilutions of 
1mM IPTG (1 mM, 0.5 mM, 0.25 mM and so on), (2) 12 wells containing 1:2 serial 
dilutions of 0.2% (w/v) L-rhamnose, and (3) 12 wells containing 1 mM of IPTG and 
1:2 serial dilutions of 0.2% (w/v) L-rhamnose. CS1:RFP/CS2:EGFP-containing cells 
were used to inoculate: (1) 12 wells containing 1:2 serial dilutions of 1mM IPTG, (2) 
12 wells containing 1:2 serial dilutions of 0.2% (w/v) L-rhamnose and (3) 12 wells 
containing 0.2% (w/v) L-rhamnose and 1:2 serial dilutions of 1 mM IPTG. 6 additional 
wells (containing LB media supplemented with 50 μg/ml kanamycin) were inoculated 
with cells bearing an empty vector.    
The cells were grown for 12 h at 37°C with shaking (1050 rpm). 200 µl aliquots of cell 
suspension were used for fluorescent measurements using SpectraMax M2e Multi-Mode 
Microplate Reader (Molecular Devices) using the following settings: 
- EGFP – excitation wavelength: 488 nm; emission wavelength: 509 nm 
- RFP – excitation wavelength: 584 nm; emission wavelength: 607 nm 
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5.4.5 Investigation of halotolerance of E. coli DH5α 
5 ml LB media (supplemented with 50 µg/ml kanamycin) was inoculated with 100 µl 
overnight culture of E. coli DH5α transformed with Multi-Genius expression vector 
(containing T5 and rhamnose promoters). When OD600 of the bacterial culture 
reached 0.5, three dilutions (1:100, 1:1000 and 1:106) of the cell suspension were 
prepared. 4 spots of each dilution (1:1, 1:100, 1:1000 and 1:106; 16 spots in total for 
each plate) were made by carefully transferring 2.5 µl aliquots of cell suspension onto 
the surface of pre-warmed LB agar plates (supplemented with different concentration of 
NaCl - 1, 2, 3, 4, 5, 6, 6.5, 7, 7.5 and 8% w/v) and allowing the excess liquid to dry. 
After 20 h of incubation at 37°C, the photographs of individual spots were taken. 
5.4.6 Investigation of thermotolerance of E. coli DH5α 
5 ml LB media (supplemented with 50 µg/ml kanamycin) was inoculated with 100 µl 
overnight culture of E. coli DH5α transformed with Multi-Genius expression vector 
(containing T5 and rhamnose promoters). When OD600 of the bacterial culture 
reached 0.5, three dilutions (1:100, 1:1000 and 1:106) of the cell suspension were 
prepared. 4 spots of each dilution (1:1, 1:100, 1:1000 and 1:106; 16 spots in total) were 
made by carefully transferring 2.5 µl aliquots of cell suspension onto the surface of pre-
warmed LB agar plates and allowing the excess liquid to dry.  
After 20 h of incubation at different temperatures (37°C, 41°C, 42°C, 43°C, 44°C, 45°C 
and 46°C), the photographs of the individual spots were taken. 
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5.4.7 Multi-Genius - application 
Genomic DNA was extracted from E. coli DH5α using Bacterial DNA Kit from 
OMEGA Bio-Tek, in accordance with manufacturer’s instructions. Genomic DNA 
from E. coli DH5α, B. coagulans, T. thermophilus and C. salexigens was amplified and 
fragmented as described in sections 4.7.4 and 4.7.5. Genomic DNA fragments in the 
range of 1.5-2 kb were isolated via gel extraction method, using NucleoSpin Gel and 
PCR Clean-up kit (Macherey Nagel) according to manufacturer’s instructions.  
DNA Polymerase I, Large (Klenow) Fragment (NEB) was used to blunt the ends of the 
isolated DNA fragments. DNA fragments from each organism were separately dissolved 
in 1x NEBuffer and supplemented with 33 μM each dNTP. 1 U of Klenow fragment 
was added to each reaction mixture. After 15 min incubation at 25°C, the reaction was 
stopped by heating the reaction mixtures for 20 min at 70°C. 
Multi-Genius expression vector was linearised at the cloning site 1 and purified as 
described in section 4.7.7. Eight ligation mixtures were prepared in parallel to join the 
linearised Multi-Genius vector with the following inserts: (1,2) E. coli DH5α genomic 
DNA fragments, (3)  B. coagulans genomic DNA fragments, (4,5) T. thermophilus 
genomic DNA fragments, (6,7) C. salexigens genomic DNA fragments, and (8) EGFP 
gene. The ligation and subsequent electroporation was carried out as described in 
section 4.7.7. 1/1000 of the electroporation outgrowth was plated on LB agar plates 
supplemented with 50 µg/ml kanamycin (and incubated overnight at 37°C) to estimate 
the cloning efficiency. The remaining transformed cells (from each electroporation) were 
transferred separately into 100 ml LB media supplemented with 50 µg/ml kanamycin 
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and 2% (w/v) glucose (instead of being plated on agar plates). The cells were grown at 
37°C with shaking (250 rpm).  When OD600 of the eight bacterial cultures reached 1 
(after about 8 h), the plasmids (containing the previously mentioned inserts integrated 
into the cloning site 1) were isolated from each culture using E.Z.N.A. Plasmid Mini 
Kit I (OMEGA Bio-Tek), in accordance with manufacturer’s instructions. 
The eight plasmid mixtures were linearised at the cloning site 2 and purified as described 
in section 4.7.7. Eight ligation mixtures were prepared in parallel to join the linearised 
plasmids with the following inserts: (1,2) E. coli DH5α genomic DNA fragments, (3,4)  
B. coagulans genomic DNA fragments, (5) T. thermophilus genomic DNA fragments, 
(6,7) C. salexigens genomic DNA fragments, and (8) RFP gene. The aim of this ligation 
step was to create the following constructs: 
(i)   CS1: E. coli DH5α gDNA; CS2: E. coli DH5α gDNA 
(ii)   CS1: E. coli DH5α gDNA; CS2: E. coli DH5α gDNA 
(iii)   CS1: B. coagulans gDNA; CS2: B. coagulans gDNA 
(iv)   CS1: T. thermophilus gDNA; CS2: B. coagulans gDNA 
(v)   CS1: T. thermophilus gDNA; CS2: T. thermophilus gDNA 
(vi)   CS1: C. salexigens gDNA; CS2: C. salexigens gDNA 
(vii) CS1: C. salexigens gDNA; CS2: C. salexigens gDNA 
(viii) CS1: egfp; CS2: rfp 
The ligation and subsequent electroporation was carried out as described in section 
4.7.7. 1/1000 of the electroporation outgrowth was plated on LB agar plates 
supplemented with 50 µg/ml kanamycin (and incubated overnight at 37°C) to estimate 
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the cloning efficiency. The remaining transformed cells (from each electroporation) were 
again transferred separately into 100 ml LB media supplemented with 50 µg/ml 
kanamycin and 2% (w/v) glucose. The cells were grown at 37°C with shaking (250 
rpm).   
When OD600 of the eight bacterial cultures reached 0.5 (after about 7-8 h), aliquots of 
the cell cultures were plated on LB agar plates supplemented with 50 µg/ml kanamycin, 
16 nM IPTG and 0.003% (w/v) L-rhamnose (corresponding to a quarter of maximum 
expression for the two promoters, as determined for RFP and EGFP via the experiment 
described in section 5.3.4). 106 cells were plated on each agar plate for constructs (i)-(iii) 
and 107 cells were used for the remaining constructs (iv)-(viii). As a result, the following 
multiplier of each library (library sizes are presented in Table 5.4) were plated for each 
construct: (i) 11, (ii) 5, (iii) 1.4, (iv) 3, (v) 5, (vi) 5 and (vii) 20. Libraries (i), (ii), (iii), 
(iv) and (v) plated were plated on the agar plates supplemented with the two inducers 
and incubated overnight at 46°C.   Libraries (i), (ii), (vi) and (vii) were plated on agar 
plates supplemented with both inducers and either 6.5 or 8% (w/v) NaCl and incubated 
overnight at 37°C.  In addition, 107 cells containing construct (viii) were plated for each 
condition to act as a negative control.  
Glycerol stocks were prepared from colonies exhibiting improved thermotolerance and 
stored in a microtiter plate at -80°C for further analysis – 30 colonies were randomly 
picked from the plate corresponding to Experiment 1 (described in Tables 5.3 and 5.4), 
24 colonies from Experiment 2, 2 colonies from Experiment 4 and 4 colonies from 
Experiment 5 (60 samples in total). 
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5.4.8 Further characterisation 
The glycerol stocks (prepared as described in Section 5.3.7) were used to inoculate a 96-
well plate containing LB media supplemented with 50 µg/ml kanamycin and 2% (w/v) 
glucose, to suppress the expression from the Multi-Genius vector. The resultant plate 
contained the isolated thermotolerant bacteria in wells B2-K7 (60 samples in total). 16 
wells in the corners of the plate (4 per each corner) contained media only. The 
remaining 20 wells were inoculated with E. coli cells containing the empty Multi-Genius 
expression vector, to act as a negative control. The plate was incubated overnight at 
37°C with shaking (1050 rpm). Subsequently, the plate was briefly centrifuged to spin 
down the cells and the supernatant was removed with a multichannel pipette. The fresh 
LB media supplemented with kanamycin only was added to each well (250 µl media per 
well) and the cells were gently resuspended. Using a multichannel pipette and 50 µl of 
cell suspension, the master plate was replicated into four plates containing LB media 
supplemented with either: (1) kanamycin, (2) kanamycin and 16 nM IPTG, (3) 
kanamycin and 0.003% (w/v) L-rhamnose, and (4) kanamycin, 16 nM IPTG and 
0.003% (w/v) L-rhamnose. The four plates were incubated with shaking at 37°C for 2h 
to induce expression from the Multi-Genius vector. Subsequently, each plate was 
manually replicated (using a standard pin replicator) into two deep-well plates 
containing LB media (1.2 ml per well) with the same inducer concentrations, 
preequilibrated at 46°C. This resulted in eight plates in total – two sets of plates with 
four different inducer concentrations. Each set of plate was quickly transferred to a 
separate incubator, preequilibrated at 46°C, and incubated with shaking for 8h. After 
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the incubation, OD600 was measured using SpectraMax M2e Multi-Mode Microplate 
Reader.  
Plasmids from 10 best-performing variants were purified using QIAprep Spin Miniprep 
Kit (Qiagen). The two inserts per plasmid were sequenced by Eurofins Genomics 
(Ebersberg, Germany) using sequencing primers listed in Section 5.3.2.  
E. coli DH5α was transformed with the isolated plasmids using a standard chemical 
transformation protocol (Minagawa et al., 2007). Glycerol stocks were prepared from 
the transformed cells and stored at -80°C for further analysis. 
The glycerol stocks were used to inoculate a 96-well plate containing LB media 
supplemented with 50 µg/ml kanamycin and 2% (w/v) glucose to suppress the 
expression from the Multi-Genius vector. Columns 2-11 were used to inoculate eight 
replicates of the ten variants (one replicate per row, for rows E-H the ten variants were 
replicated in reverse – with the first variant in column 11). The columns 1 and 12 were 
inoculated with E. coli cells containing the empty Multi-Genius expression vector, to act 
as a negative control. The plate was incubated overnight at 37°C with shaking 
(1050 rpm). Subsequently, the plate was briefly centrifuged to spin down the cells and 
the supernatant was removed with a multichannel pipette. 250 µl fresh LB media was 
added to each well supplemented with (1) kanamycin only for rows A and H, (2) 
kanamycin and 16 nM IPTG for rows B and G, (3) kanamycin and 0.003% (w/v) L-
rhamnose for rows C and F, and (4) kanamycin, 16 nM IPTG and 0.003% (w/v) L-
rhamnose for rows D and E. Immediately afterwards, the cells were gently resuspended. 
The plate was incubated with shaking at 37°C for 2h to induce expression from the 
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Multi-Genius vector. Subsequently, the master plate was manually replicated (using a 
standard pin replicator) into eight deep-well plates containing LB media (1.2 ml per 
well) with the same inducer concentrations, preequilibrated at 46°C. The plates were 
quickly transferred to a separate incubator, preequilibrated at 46°C, and incubated with 
shaking for 8h. After the incubation, OD600 was measured using SpectraMax M2e 
Multi-Mode Microplate Reader.  
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Chapter 6 
 
Conclusions and future 
work 
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6.1 Conclusions 
The aim of the presented research was to expand molecular toolbox for synthetic biology 
allowing a more efficient access to largely untapped potential of biological diversity. This 
was achieved via the development of two molecular methods: QuickStep-Cloning and 
Multi-Genius. 
QuickStep-Cloning utilises recent advances in megaprimer-based cloning to allow for 
seamless integration of a DNA fragment of interest into a plasmid in less than 6 hours – 
the result that could not be reproduced using traditional cloning or state-of-the-art 
methods such as restriction-free (RF) cloning. Owing to its rapid protocol and general 
simplicity, QuickStep-Cloning also compares favourably with four recently-reported 
strategies of exponential megaprimer-based cloning (ABI-REC, RAM cloning, EMP 
cloning and IFPC). 
The applicability of QuickStep-Cloning is certainly not limited to standard cloning 
experiments, involving transfer of a gene sequence from a donor vector to a recipient 
plasmid. The developed method could be especially useful for protein tagging or, 
potentially, cloning DNA fragments directly from genomic DNA. In general, the 
method should constitute a useful tool for facilitating the vital process of constructing 
and testing new biological circuits by allowing faster integration of genetic elements. As 
such, QuickStep-Cloning should find its applications in the developing fields of protein 
engineering, metabolic engineering and synthetic biology. 
 The new improved version of the method, QuickStepS-Cloning, uses phosphorothioate 
oligonucleotides to not only simplify the overall procedure but also significantly increase 
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its cloning efficiency. It also shown that incorporating random mutagenesis into the 
method allows for streamlining directed evolution experiments. It is shown that 
QuickStepS-Cloning cloning can compete with even the most efficient methods of 
incorporating combinatorial libraries, such as MEGAWHOP. All in all, the developed 
method constitute an excellent addition to a general molecular toolbox. QuickStepS-
Cloning should be of great interest to synthetic biology because not only it facilitates the 
construction of biological circuits (expanding the capabilities and the throughput of the 
previous method) but also, when used in combination with directed evolution, it can 
expedite the process of acquiring new biological parts.  
Whereas the potential applications of QuickStep-Cloning revolve around artificially-
induced diversity, Multi-Genius expands upon the concept of genomic libraries to tap 
into naturally-existing diversity and expedite identification of genes encoding for useful 
phenotypes. The method addresses significant limitations and lacking features in the 
area of identifying genes encoding for useful phenotypes, including the recently-reported 
strategy of Coexisting/Coexpressing Genomic Libraries, CoGeLs. Among other things, 
Multi-Genius expands the concept of screening multiple genes (in search of DNA 
fragments encoding for complex phenotypes) to genomic elements originating from 
exogenous genomic DNA. As such, the method broadens the repertoire of molecular 
tools for acquiring new biological parts. What is more, Multi-Genius utilises the concept 
of modular expression to address the problem of biological complexity. The use of two 
orthogonal, inducible promoters allow for studying the interplay between individual 
genetic elements and optimise the performance of resultant biological systems by fine-
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tuning the expression of individual genes. All in all, the method ties together different 
concepts and techniques associated with molecular biology to offer a streamlined 
protocol for uncovering and studying interactions between distant genes. The potential 
of the method is demonstrated by isolating thermotolerant variants of E. coli DH5α. 
Even though, the usefulness of modular expression could not be showcased in this series 
of experiments, the applicability of the method to synthetic biology and other the field is 
clearly shown. 
It is worth noting that the two methods, QuickStep-Cloning and Multi-Genius, clearly 
complement themselves. Multi-Genius allows for tapping into the natural diversity and 
helps to identify new genes encoding for useful phenotypes. QuickStep-Cloning, on the 
other hand, expedites the way in which known genes are being engineered - e.g., 
through the process of directed evolution - to create fit-for-purpose genetic parts.  
All things considered, both QuickStep-Cloning and Multi-Genius expand the molecular 
toolbox available to synthetic biologists and enhance the way biodiversity is being 
studied and utilised.  
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6.2 Future work 
In the short term, the role of thyA (encoding for thymidylate synthase) for improving 
thermotolerance in Escherichia coli DH5α should be further investigated. This should be 
achieved by: 
- cloning the gene from B. coagulans into a common expression vector 
- comparing the growth rate of E. coli cells transformed with the constructed 
plasmid with those that contain the empty expression vector (acting as a negative 
control) at elevated temperatures - e.g., 46°C   
If the increase in the thermotolerance is very significant, the identified genes can be 
integrated into the genome of E. coli, to create a new, thermotolerant strain that might 
be of some industrial interest. There is also a potential for employing protein 
engineering to investigate whether the thermotolerance of E. coli cells can be further 
enhanced by increasing the thermostability of the enzyme. QuickStepS-Cloning would 
prove invaluable in such an experiment. 
In the long term, it would be desirable to utilise Multi-Genius in conjunction with 
various different genomic libraries to identify new genes encoding for other useful 
phenotypes. It would also be desirable to showcase the usefulness of modular expression 
featured in Multi-Genius. This should be achieved by: 
- isolating a bacterial colony exhibiting a particular phenotype in which the phenotype is 
encoded by a two-gene combination  
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- conducting sequencing of the extracted plasmid to identify genes encoding for the 
phenotype and elucidate the underlined mechanism 
-  transforming native E. coli DH5α with the isolated plasmid and demonstrating that 
the observed change in the phenotype comes solely from the plasmid 
- utilising microtiter plates or agar plates with varying concentrations of the inducer to 
identify the optimal expression levels of the two genes encoding for the phenotype 
It is also envisaged that the efficiency of QuickStepS-Cloning could be further increased 
through further experiments and general optimisation.  
Ultimately, Multi-Genius and QuickStepS-Cloning could be combined together to 
provide a comprehensive protocol for streamlined acquisition of fit-for-purpose genetic 
parts by (1) tapping into natural diversity and (2) further engineering the identified 
genes via directed evolution.  
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